Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Medical Cannabis Program Amendments
Number
S.B. 121 (2026GS)
Sponsor
Sen. Vickers, Evan J.
Final action
Governor Signed 3/26/2026
Outcome
Became law — signed by Gov. Spencer J. Cox

Summary

This bill amends provisions related to the medical cannabis program.

What it does

  • This bill:
  • defines terms;
  • amends when the Cannabis Production Establishment and Pharmacy Licensing Advisory Board must meet to review an ownership change application;
  • amends provisions related to labeling of cannabis products;
  • amends provisions related to cannabis remediation;
  • repeals language related to electronic payments;
  • amends how medical cannabis cardholders may transport medical cannabis;
  • enacts provisions related to the safe storage of medical cannabis for medical cannabis deliveries;
  • amends provisions related to when a recommending provider employee may access information;
  • amends provisions related to the processes of obtaining certain medical cannabis cards;
  • amends provisions related to when a medical cannabis pharmacy agent may access the electronic verification system;
  • amends provisions related to acceptable forms of identification;
  • amends provisions related to the revocation of certain medical cannabis agent cards;
  • allows a medical cannabis guardian card to be issued to the legal guardian of an adult who is incapacitated;

Every vote on this bill

2026-01-26Senate Comm - Favorable Recommendation
Senate Health and Human Services Committee
4-0-3not eligible / no record
2026-02-17House Comm - Favorable Recommendation
House Natural Resources, Agriculture, and Environment Committee
9-0-5not eligible / no record
2026-02-09Senate/ substituted
Senate 2nd Reading Calendar
0-0-29not eligible / no record
2026-02-09Senate/ passed 2nd reading
Senate 3rd Reading Calendar
28-0-1not eligible / no record
2026-02-10Senate/ passed 3rd reading
Clerk of the House
27-0-2not eligible / no record
2026-02-19House/ passed 3rd reading
House Speaker
68-1-6YEA

Bill text

enrolled version · official source
62
4-41a-201
4-41a-501
4-41a-602
4-41a-1001
4-41a-1101
4-41a-1106
4-41a-1201
4-41a-1204
4-41a-1205
26B-1-310
26B-1-421
26B-4-201
26B-4-202
26B-4-213
26B-4-214
26B-4-215
26B-4-248
63I-2-236
6
Medical Cannabis Program Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Evan J. Vickers
House Sponsor: Walt Brooks
LONG TITLE
General Description:
This bill amends provisions related to the medical cannabis program.
Highlighted Provisions:
This bill:
defines terms;
amends when the Cannabis Production Establishment and Pharmacy Licensing Advisory 
Board must
 meet to review an ownership change application;
amends provisions related to labeling of cannabis products;
amends provisions related to cannabis remediation;
repeals language related to electronic payments;
amends how medical cannabis cardholders may transport medical cannabis;
enacts provisions related to the safe storage of medical cannabis for medical cannabis 
deliveries;
amends provisions related to when a recommending provider employee may access 
information;
amends provisions related to the processes of obtaining certain medical cannabis cards;
amends provisions related to when a medical cannabis pharmacy agent may access the 
electronic verification system;
amends provisions related to acceptable forms of identification;
amends provisions related to the revocation of certain medical cannabis agent cards;
allows a medical cannabis guardian card to be issued to the legal guardian of an adult who 
is incapacitated;
creates a voucher program for patients to obtain medical cannabis or a medical cannabis 
device; 
extends the repeal of the medical cannabis governance structure working group; and
makes technical and conforming changes.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
4-41a-201
, as last amended by Laws of Utah 2025, Chapter 414
4-41a-501
, as last amended by Laws of Utah 2025, Chapter 114
4-41a-602
, as last amended by Laws of Utah 2025, Chapter 392
4-41a-1001
, as last amended by Laws of Utah 2025, Chapters 114, 277 and 414
4-41a-1101
, as last amended by Laws of Utah 2025, Chapter 392
4-41a-1106
, as last amended by Laws of Utah 2025, Chapter 414
4-41a-1201
, as last amended by Laws of Utah 2025, Chapter 114
4-41a-1204
, as last amended by Laws of Utah 2025, Chapter 414
4-41a-1205
, as last amended by Laws of Utah 2023, Chapter 317 and renumbered and 
amended by Laws of Utah 2023, Chapters 273, 307 and last amended by Coordination Clause, 
Laws of Utah 2023, Chapter 307
26B-1-310
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
26B-1-421
, as last amended by Laws of Utah 2025, Chapter 494
26B-4-201
, as last amended by Laws of Utah 2025, Chapter 392
26B-4-202
, as last amended by Laws of Utah 2025, Chapter 392
26B-4-213
, as last amended by Laws of Utah 2025, Chapter 392
26B-4-214
, as last amended by Laws of Utah 2025, Chapter 392
63I-2-236
, as last amended by Laws of Utah 2025, Chapters 277, 414
ENACTS:
26B-4-248
, Utah Code Annotated 1953
REPEALS:
26B-4-215
, as renumbered and amended by Laws of Utah 2023, Chapter 307
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
4-41a-201
 is amended to read:
4-41a-201
. Cannabis production establishment -- License.
(1)
Except as provided in Subsection 
(14)
, a person may not operate a cannabis production 
establishment without a license that the department issues under this chapter.
(2)
(a)
(i)
Subject to Subsections 
(6)
, 
(7)
, 
(8)
, and 
(13)
 and to Section 
4-41a-205
, for a 
licensing process that the department initiates after March 17, 2021, the 
department, through the licensing board, shall issue licenses in accordance with 
Section 
4-41a-201.1
.
(ii)
In accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, 
the department shall make rules to specify a transparent and efficient process to:
(A)
solicit applications for a license under this section;
(B)
allow for comments and questions in the development of applications;
(C)
timely and objectively evaluate applications;
(D)
hold public hearings that the department deems appropriate; and
(E)
select applicants to receive a license.
(iii)
The department may not issue a license to operate a cannabis production 
establishment to an applicant who is not eligible for a license under this section.
(b)
An applicant is eligible for a license under this section if the applicant submits to the 
licensing board:
(i)
subject to Subsection 
(2)(c)
, a proposed name and each address, located in a zone 
described in Subsection 
4-41a-406(2)(a)
 or 
(b)
, where the applicant will operate 
the cannabis production establishment;
(ii)
the name and address of any individual who has:
(A)
for a publicly traded company, a financial or voting interest of 10% or greater 
in the proposed cannabis production establishment;
(B)
for a privately held company, a financial or voting interest in the proposed 
cannabis production establishment; or
(C)
the power to direct or cause the management or control of a proposed cannabis 
production establishment;
(iii)
an operating plan that:
(A)
complies with Section 
4-41a-204
;
(B)
includes operating procedures that comply with this chapter and any law the 
municipality or county in which the person is located adopts that is consistent 
with Section 
4-41a-406
; and
(C)
the department or licensing board approves;
(iv)
a statement that the applicant will obtain and maintain a liquid cash account with 
a financial institution or a performance bond that a surety authorized to transact 
surety business in the state issues in an amount of at least:
(A)
$100,000 for each cannabis cultivation facility for which the applicant applies; 
or
(B)
$50,000 for each cannabis processing facility or independent cannabis testing 
laboratory for which the applicant applies;
(v)
an application fee in an amount that, subject to Subsection 
4-41a-104(5)
, the 
department sets in accordance with Section 
63J-1-504
; and
(vi)
a description of any investigation or adverse action taken by any licensing 
jurisdiction, government agency, law enforcement agency, or court in any state for 
any violation or detrimental conduct in relation to any of the applicant's 
cannabis-related operations or businesses.
(c)
(i)
A person may not locate a cannabis production establishment:
(A)
within 1,000 feet of a community location; or
(B)
in or within 600 feet of a district that the relevant municipality or county has 
zoned as primarily residential.
(ii)
The proximity requirements described in Subsection 
(2)(c)(i)
 shall be measured 
from the nearest entrance to the cannabis production establishment by following 
the shortest route of ordinary pedestrian travel to the property boundary of the 
community location or residential area.
(iii)
The licensing board may grant a waiver to reduce the proximity requirements in 
Subsection 
(2)(c)(i)
 by up to 20% if the licensing board determines that it is not 
reasonably feasible for the applicant to site the proposed cannabis production 
establishment without the waiver.
(iv)
An applicant for a license under this section shall provide evidence of 
compliance with the proximity requirements described in Subsection 
(2)(c)(i)
.
(3)
If the licensing board approves an application for a license under this section and 
Section 
4-41a-201.1
:
(a)
the applicant shall pay the department an initial license fee in an amount that, subject 
to Subsection 
4-41a-104(5)
, the department sets in accordance with Section 
63J-1-504
; 
and
(b)
the department shall notify the Department of Public Safety of the license approval 
and the names of each individual described in Subsection 
(2)(b)(ii)
.
(4)
(a)
Except as provided in this Subsection 
(4)
, a cannabis production establishment 
shall obtain a separate license for each type of cannabis production establishment and 
each location of a cannabis production establishment.
(b)
The licensing board may issue a cannabis cultivation facility license and a cannabis 
processing facility license to a person to operate at the same physical location or at 
separate physical locations.
(c)
A cannabis cultivation facility may operate at two addresses under a single license.
(d)
A tier one cannabis processing facility may operate at a second address under the 
same tier one license if:
(i)
the second address is co-located at a cannabis cultivation facility operated by the 
same licensee; and
(ii)
the licensee pays a fee of $70,000 for the second location.
(e)
An applicant for a tier two cannabis processing facility license that has a cannabis 
cultivation facility license and intends to process cannabis at the cannabis cultivation 
facility shall pay a fee of $25,000 for the tier two cannabis processing facility license.
(5)
If the licensing board receives more than one application for a cannabis production 
establishment within the same city or town, the licensing board shall consult with the 
local land use authority before approving any of the applications pertaining to that city 
or town.
(6)
The licensing board may not issue a license to operate an independent cannabis testing 
laboratory to a person who:
(a)
holds a license or has an ownership interest in a medical cannabis pharmacy, a 
cannabis processing facility, or a cannabis cultivation facility;
(b)
has an owner, officer, director, or employee whose family member holds a license or 
has an ownership interest in a medical cannabis pharmacy, a cannabis processing 
facility, or a cannabis cultivation facility; or
(c)
proposes to operate the independent cannabis testing laboratory at the same physical 
location as a medical cannabis pharmacy, a cannabis processing facility, or a 
cannabis cultivation facility.
(7)
The licensing board may not issue a license to operate a cannabis production 
establishment to an applicant if any individual described in Subsection 
(2)(b)(ii)
:
(a)
has been convicted under state or federal law of:
(i)
a felony in the preceding 10 years; or
(ii)
after December 3, 2018, a misdemeanor for drug distribution;
(b)
is younger than 21 years old; or
(c)
after September 23, 2019, until January 1, 2023, is actively serving as a legislator.
(8)
(a)
If an applicant for a cannabis production establishment license under this section 
holds a license under 
Title 4, 
Chapter 41, Hemp and Cannabinoid Act, the licensing 
board may not give preference to the applicant based on the applicant's status as a 
holder of the license.
(b)
If an applicant for a license to operate a cannabis cultivation facility under this 
section holds a license to operate a medical cannabis pharmacy under this title, the 
licensing board may give consideration to the applicant based on the applicant's 
status as a holder of a medical cannabis pharmacy license if:
(i)
the applicant demonstrates that a decrease in costs to patients is more likely to 
result from the applicant's vertical integration than from a more competitive 
marketplace; and
(ii)
the licensing board finds multiple other factors, in addition to the existing license, 
that support granting the new license.
(9)
The licensing board may revoke a license under this part:
(a)
if the cannabis production establishment does not begin cannabis production 
operations within one year after the day on which the licensing board issues the 
initial license;
(b)
after the third of the same violation of this chapter in any of the licensee's licensed 
cannabis production establishments or medical cannabis pharmacies;
(c)
if any individual described in Subsection 
(2)(b)
 is convicted, while the license is 
active, under state or federal law of:
(i)
a felony; or
(ii)
after December 3, 2018, a misdemeanor for drug distribution;
(d)
if the licensee fails to provide the information described in Subsection 
(2)(b)(vi)
 at 
the time of application, or fails to supplement the information described in 
Subsection 
(2)(b)(vi)
 with any investigation or adverse action that occurs after the 
submission of the application within 14 calendar days after the licensee receives 
notice of the investigation or adverse action;
(e)
if the cannabis production establishment demonstrates a willful or reckless disregard 
for the requirements of this chapter or the rules the department makes in accordance 
with this chapter;
(f)
if, after a change of ownership described in Subsection 
(15)(b)
, the board determines 
that the cannabis production establishment no longer meets the minimum standards 
for licensure and operation of the cannabis production establishment described in this 
chapter;
(g)
for an independent cannabis testing laboratory, if the independent cannabis testing 
laboratory fails to substantially meet the performance standards described in 
Subsection 
(14)(b)
; or
(h)
if, following an investigation conducted 
pursuant to
under
 Subsection 
4-41a-201.1(11)
, the board finds that the licensee has participated in an 
anticompetitive business practice.
(10)
(a)
A person who receives a cannabis production establishment license under this 
chapter, if the municipality or county where the licensed cannabis production 
establishment will be located requires a local land use permit, shall submit to the 
licensing board a copy of the licensee's approved application for the land use permit 
within 120 days after the day on which the licensing board issues the license.
(b)
If a licensee fails to submit to the licensing board a copy of the licensee's approved 
land use permit application in accordance with Subsection 
(10)(a)
, the licensing 
board may revoke the licensee's license.
(11)
The department shall deposit the proceeds of a fee that the department imposes under 
this section into the Qualified Production Enterprise Fund.
(12)
The department shall begin accepting applications under this part on or before January 
1, 2020.
(13)
(a)
The department's authority, and consequently the licensing board's authority, to 
issue a license under this section is plenary and is not subject to review.
(b)
Notwithstanding Subsection 
(2)(a)(ii)(A)
(2)(a)(i)
, the decision of the department to 
award a license to an applicant is not subject to:
(i)
Title 63G, Chapter 6a, Part 16, Protests; or
(ii)
Title 63G, Chapter 6a, Part 17, Procurement Appeals Board.
(14)
(a)
Notwithstanding this section, the department:
(i)
may operate or partner with a research university to operate an independent 
cannabis testing laboratory;
(ii)
if the department operates or partners with a research university to operate an 
independent cannabis testing laboratory, may not cease operating or partnering 
with a research university to operate the independent cannabis testing laboratory 
unless:
(A)
the department issues at least two licenses to independent cannabis testing 
laboratories; and
(B)
the department has ensured that the licensed independent cannabis testing 
laboratories have sufficient capacity to provide the testing necessary to support 
the state's medical cannabis market; and
(iii)
after ceasing department or research university operations under Subsection 
(14)(a)(ii)
 shall resume independent cannabis testing laboratory operations at any 
time if:
(A)
fewer than two licensed independent cannabis testing laboratories are 
operating; or
(B)
the licensed independent cannabis testing laboratories become, in the 
department's determination, unable to fully meet the market demand for testing.
(b)
(i)
The department shall make rules, in accordance with Title 63G, Chapter 3, 
Utah Administrative Rulemaking Act, to establish performance standards for the 
operation of an independent cannabis testing laboratory, including deadlines for 
testing completion.
(ii)
A license that the department issues to an independent cannabis testing laboratory 
is contingent upon substantial satisfaction of the performance standards described 
in Subsection 
(14)(b)(i)
, as determined by the board.
(15)
(a)
A cannabis production establishment license is not transferrable or assignable.
(b)
If the ownership of a cannabis production establishment changes by 50% or more:
(i)
the cannabis production establishment shall submit a new application described in 
Subsection 
(2)(b)
, subject to Subsection 
(2)(c)
;
(ii)
within 
30
60
 days of the submission of the application, the board shall:
(A)
conduct the application review described in Section 
4-41a-201.1
; and
(B)
award a license to the cannabis production establishment for the remainder of 
the term of the cannabis production establishment's license before the 
ownership change if the cannabis production establishment meets the minimum 
standards for licensure and operation of the cannabis production establishment 
described in this chapter; and
(iii)
if the board approves the license application, notwithstanding Subsection 
(3)
, the 
cannabis production establishment shall pay a license fee that the department sets 
in accordance with Section 
63J-1-504
 in an amount that covers the board's cost of 
conducting the application review.
Section 2. Section 
4-41a-501
 is amended to read:
4-41a-501
. Cannabis cultivation facility -- Operating requirements.
(1)
A cannabis cultivation facility shall ensure that any cannabis growing at the cannabis 
cultivation facility is not visible from the ground level of the cannabis cultivation facility 
perimeter.
(2)
A cannabis cultivation facility shall use a unique identifier that is connected to the 
facility's inventory control system to identify:
(a)
beginning at the time a cannabis plant is eight inches tall and has a root ball, each 
cannabis plant;
(b)
each unique harvest of cannabis plants;
(c)
each batch of cannabis the facility transfers to a medical cannabis pharmacy, a 
cannabis processing facility, or an independent cannabis testing laboratory; and
(d)
any excess, contaminated, or deteriorated cannabis of which the cannabis cultivation 
facility disposes.
(3)
A cannabis cultivation facility shall identify cannabis biomass as cannabis byproduct or 
cannabis plant product before transferring the cannabis biomass from the facility.
(4)
A cannabis cultivation facility shall either:
(a)
ensure that a cannabis processing facility chemically or physically processes 
cannabis cultivation byproduct to produce a cannabis concentrate for incorporation 
into cannabis derivative products; or
(b)
destroy cannabis cultivation byproduct in accordance with Section 
4-41a-405
.
(5)
(a)
A cannabis cultivation facility may
 utilize radiation-based methods and 
equipment
,
 for quality assurance or remediation purposes
, use methods and 
equipment as approved by the department through rule
.
(b)
The department shall allow the use of radiation-based methods and equipment in 
rules created under Subsection 
(5)(a)
.
(6)
The department shall make rules establishing:
(a)
the records a cannabis cultivation facility
must
s
h
a
l
l
 keep
 regarding each batch, 
amount of product treated, and the methods used; and
(b)
disclosure requirements to a cannabis processor receiving the material subject to the 
radiation including the methods and equipment used.
Section 3. Section 
4-41a-602
 is amended to read:
4-41a-602
. Cannabis product -- Labeling and child-resistant packaging.
(1)
For any cannabis product that a cannabis processing facility processes or produces and 
for any raw cannabis that the facility packages, the facility shall:
(a)
label the cannabis or cannabis product with a label that:
(i)
clearly and unambiguously states that the cannabis product or package contains 
cannabis;
(ii)
clearly displays the amount of total composite tetrahydrocannabinol, cannabidiol, 
and any known cannabinoid that is greater than 1% of the total cannabinoids 
contained in the cannabis or cannabis product as determined under Subsection 
4-41a-701(4)
;
(iii)
has a unique identification number that:
(A)
is connected to the inventory control system; and
(B)
identifies the unique cannabis product manufacturing process the cannabis 
processing facility used to manufacture the cannabis product;
(iv)
identifies the cannabinoid extraction process that the cannabis processing facility 
used to create the cannabis product;
(v)
does not display an image, word, or phrase that the facility knows or should know 
appeals to children; and
(vi)
discloses each active or potentially active ingredient, in order of prominence, and 
possible allergen; and
(b)
package the raw cannabis or cannabis product in a medicinal dosage form in a 
container that:
(i)
is tamper evident and tamper resistant;
(ii)
does not appeal to children;
(iii)
does not mimic a candy container;
(iv)
complies with child-resistant effectiveness standards that the United States 
Consumer Product Safety Commission establishes;
(v)
includes a warning label that states:
(A)
for a container labeled on or after January 1, 2024, "WARNING: Cannabis 
has intoxicating effects, may be addictive, and may increase risk of mental 
illness. Do not operate a vehicle or machinery under its influence. KEEP OUT 
OF REACH OF CHILDREN. This product is for medical use only. Use only as 
directed by a recommending medical provider."; or
(B)
for a container labeled on or after January 1, 2026, "WARNING: Cannabis 
use by pregnant or breastfeeding women, may result in fetal injury, preterm 
birth, or developmental problems for the child. Cannabis may be addictive and 
may increase risk of mental illness. Do not operate a vehicle or machinery 
under its influence. KEEP OUT OF REACH OF CHILDREN. This product is 
for medical use only. Use only as directed by a recommending medical 
provider."; and
(vi)
for raw cannabis or a cannabis product sold in a vaporizer cartridge labeled on or 
after May 3, 2023, includes a warning label that states:
(A)
"WARNING: Vaping of cannabis-derived products has been associated with 
lung injury."; and
(B)
"WARNING: Inhalation of cannabis smoke has been associated with lung 
injury.".
(2)
(a)
To 
Except as provided in Subsection 
(2)(b)
, to 
ensure that a cannabis product 
that a cannabis processing facility processes or produces has a medical rather than 
recreational disposition, the facility may not produce or process a product whose 
logo, product name, or brand name includes terms related to recreational marijuana, 
including "weed," "pot," "reefer," "grass," "hash," "ganja," "Mary Jane," "high," 
"haze," "stoned," "joint," "bud," "smoke," "euphoria," "dank," "doobie," "kush," 
"frost," "cookies," "rec," "bake," "blunt," "combust," "bong," "budtender," "dab," 
"blaze," "toke," or "420."
(b)
A product name may contain the word "hash."
(3)
For any cannabis or cannabis product that the cannabis processing facility processes into 
a gelatinous cube, gelatinous rectangular cuboid, or lozenge in a cube or rectangular 
cuboid shape, the facility shall:
(a)
ensure that the label described in Subsection 
(1)(a)
 does not contain a photograph or 
other image of the content of the container; and
(b)
include on the label described in Subsection 
(1)(a)
 a warning about the risks of 
over-consumption.
(4)
For any cannabis product that contains an artificially derived cannabinoid, the cannabis 
processing facility shall ensure that the label clearly:
(a)
identifies each artificially derived cannabinoid; and
(b)
identifies that each artificially derived cannabinoid is an artificially derived 
cannabinoid.
(5)
In accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the 
department:
(a)
shall make rules to establish:
(i)
a standard labeling format that:
(A)
complies with the requirements of this section; and
(B)
ensures inclusion of a pharmacy label; and
(ii)
additional requirements on packaging for cannabis and cannabis products to 
ensure safety and product quality; 
and
(b)
may make rules to further define standards regarding images, words, phrases, or 
containers that may appeal to children under Subsection 
(1)(a)(v)
 or 
(1)(b)(ii)
.
; and
(c)
may make rules to regulate the use of common terms describing a potential 
physiological effect on medical cannabis labels.
Section 4. Section 
4-41a-1001
 is amended to read:
4-41a-1001
. Medical cannabis pharmacy -- License -- Eligibility.
(1)
A person may not:
(a)
 operate as a medical cannabis pharmacy without a license that the department issues 
under this part;
(b)
obtain a medical cannabis pharmacy license if obtaining the license would cause the 
person to exceed the pharmacy ownership limit;
(c)
obtain a partial ownership share of a medical cannabis pharmacy if obtaining the 
partial ownership share would cause the person to exceed the pharmacy ownership 
limit; or
(d)
enter into any contract or agreement that allows the person to directly or indirectly 
control the operations of a medical cannabis pharmacy if the person's control of the 
medical cannabis pharmacy would cause the person to effectively exceed the 
pharmacy ownership limit.
(2)
(a)
(i)
Subject to Subsections 
(4)
 and 
(5)
 and to Section 
4-41a-1005
, the licensing 
board shall issue a license to operate a medical cannabis pharmacy.
(ii)
The licensing board may not issue a license to operate a medical cannabis 
pharmacy to an applicant who is not eligible for a license under this section.
(b)
An applicant is eligible for a license under this section if the applicant submits to the 
licensing board:
(i)
subject to Subsection 
(2)(c)
, a proposed name and address where the applicant will 
operate the medical cannabis pharmacy;
(ii)
the name and address of an individual who:
(A)
for a publicly traded company, has a financial or voting interest of 10% or 
greater in the proposed medical cannabis pharmacy;
(B)
for a privately held company, a financial or voting interest in the proposed 
medical cannabis pharmacy; or
(C)
has the power to direct or cause the management or control of a proposed 
medical cannabis pharmacy;
(iii)
for each application that the applicant submits to the department, a statement 
from the applicant that the applicant will obtain and maintain:
(A)
a performance bond in the amount of $100,000 issued by a surety authorized 
to transact surety business in the state; or
(B)
a liquid cash account in the amount of $100,000 with a financial institution;
(iv)
an operating plan that:
(A)
complies with Section 
4-41a-1004
;
(B)
includes operating procedures to comply with the operating requirements for a 
medical cannabis pharmacy described in this part and with a relevant municipal 
or county law that is consistent with Section 
4-41a-1106
; and
(C)
the department approves;
(v)
an application fee in an amount that, subject to Subsection 
4-41a-104(5)
, the 
department sets in accordance with Section 
63J-1-504
; and
(vi)
a description of any investigation or adverse action taken by any licensing 
jurisdiction, government agency, law enforcement agency, or court in any state for 
any violation or detrimental conduct in relation to any of the applicant's 
cannabis-related operations or businesses.
(c)
(i)
A person may not locate a medical cannabis pharmacy:
(A)
within 200 feet of a community location; or
(B)
in or within 600 feet of a district that the relevant municipality or county has 
zoned as primarily residential.
(ii)
The proximity requirements described in Subsection 
(2)(c)(i)
 shall be measured 
from the nearest entrance to the medical cannabis pharmacy establishment by 
following the shortest route of ordinary pedestrian travel to the property boundary 
of the community location or residential area.
(iii)
The licensing board may grant a waiver to reduce the proximity requirements in 
Subsection 
(2)(c)(i)
 by up to 20% if the department determines that it is not 
reasonably feasible for the applicant to site the proposed medical cannabis 
pharmacy without the waiver.
(iv)
An applicant for a license under this section shall provide evidence of 
compliance with the proximity requirements described in Subsection 
(2)(c)(i)
.
(d)
The licensing board may not issue a license to an eligible applicant that the 
department has selected to receive a license until the selected eligible applicant 
complies with the bond or liquid cash requirement described in Subsection 
(2)(b)(iii)
.
(e)
If the licensing board receives more than one application for a medical cannabis 
pharmacy within the same city or town, the department shall consult with the local 
land use authority before approving any of the applications pertaining to that city or 
town.
(f)
In considering the issuance of a medical cannabis pharmacy license under this 
section, the licensing board may consider the extent to which the pharmacy can 
increase efficiency and reduce cost to patients of medical cannabis.
(3)
(a)
After an entity has been selected for a medical cannabis pharmacy license under 
this section, the department shall:
(i)
charge the applicant an initial license fee in an amount that, subject to Subsection 
4-41a-104(5)
, the department sets in accordance with Section 
63J-1-504
;
(ii)
notify the Department of Public Safety of the license approval and the names of 
each individual described in Subsection 
(2)(b)(ii)
; and
(iii)
charge the licensee a fee in an amount that, subject to Subsection 
4-41a-104(5)
, 
the department sets in accordance with Section 
63J-1-504
, for any change in 
location, ownership, or company structure.
(b)
For a fee described in Subsection 
(3)(a)(i)
, a license fee for a medical cannabis 
pharmacy located in a medically underserved area as determined by the federal 
Health Resources and Services Administration shall be 50% less than what is charged 
for other medical cannabis pharmacies.
(4)
The licensing board may not issue a license to operate a medical cannabis pharmacy to 
an applicant if an individual described in Subsection 
(2)(b)(ii)
:
(a)
has been convicted under state or federal law of:
(i)
a felony in the preceding 10 years; or
(ii)
after December 3, 2018, a misdemeanor for drug distribution;
(b)
is younger than 21 years old; or
(c)
after September 23, 2019, until January 1, 2023, is actively serving as a legislator.
(5)
If an applicant for a medical cannabis pharmacy license under this section holds another 
license under this chapter, the licensing board may not give preference to the applicant 
based on the applicant's status as a holder of the license.
(6)
The licensing board may revoke a license under this part:
(a)
if the medical cannabis pharmacy does not begin operations within one year after the 
day on which the department issues an announcement of the department's intent to 
award a license to the medical cannabis pharmacy;
(b)
after the third of the same violation of this chapter in any of the licensee's licensed 
cannabis production establishments or medical cannabis pharmacies;
(c)
if an individual described in Subsection 
(2)(b)(ii)
 is convicted, while the license is 
active, under state or federal law of:
(i)
a felony; or
(ii)
after December 3, 2018, a misdemeanor for drug distribution;
(d)
if the licensee fails to provide the information described in Subsection 
(2)(b)(vi)
 at 
the time of application, or fails to supplement the information described in 
Subsection 
(2)(b)(vi)
 with any investigation or adverse action that occurs after the 
submission of the application within 14 calendar days after the licensee receives 
notice of the investigation or adverse action;
(e)
if the medical cannabis pharmacy demonstrates a willful or reckless disregard for the 
requirements of this chapter or the rules the department makes in accordance with 
this chapter; 
(f)
if, after a change of ownership described in Subsection 
(10)(c)
, the department 
determines that the medical cannabis pharmacy no longer meets the minimum 
standards for licensure and operation of the medical cannabis pharmacy described in 
this chapter; or
(g)
if through an investigation conducted under Subsection 
4-41a-201.1(11)
 and in 
accordance with Title 63G, Chapter 4, Administrative Procedures Act, the licensing 
board finds that the licensee has participated in anticompetitive business practices.
(7)
(a)
A person who receives a medical cannabis pharmacy license under this chapter, if 
the municipality or county where the licensed medical cannabis pharmacy will be 
located requires a local land use permit, shall submit to the department a copy of the 
licensee's approved application for the land use permit within 120 days after the day 
on which the department issues the license.
(b)
If a licensee fails to submit to the department a copy the licensee's approved land use 
permit application in accordance with Subsection 
(7)(a)
, the department may revoke 
the licensee's license.
(8)
The department shall deposit the proceeds of a fee imposed by this section into the 
Qualified Production Enterprise Fund.
(9)
(a)
The licensing board's authority to issue a license under this section is plenary and 
is not subject to review.
(b)
Notwithstanding Subsection 
(2)
, the decision of the department to award a license to 
an applicant is not subject to:
(i)
Title 63G, Chapter 6a, Part 16, Protests; or
(ii)
Title 63G, Chapter 6a, Part 17, Procurement Appeals Board.
(10)
(a)
A medical cannabis pharmacy license is not transferrable or assignable.
(b)
A medical cannabis pharmacy shall report in writing to the department no later than 
45 business days before the date of any change of ownership of the medical cannabis 
pharmacy.
(c)
If the ownership of a medical cannabis pharmacy changes by 50% or more:
(i)
concurrent with the report described in Subsection 
(10)(b)
, the medical cannabis 
pharmacy shall submit a new application described in Subsection 
(2)(b)
, subject to 
Subsection 
(2)(c)
;
(ii)
within 
30
60
 days of the submission of the application, the licensing board shall:
(A)
conduct an application review; and
(B)
award a license to the medical cannabis pharmacy for the remainder of the 
term of the medical cannabis pharmacy's license before the ownership change 
if the medical cannabis pharmacy meets the minimum standards for licensure 
and operation of the medical cannabis pharmacy described in this chapter; and
(iii)
if the department approves the license application, notwithstanding Subsection 
(3)
, the medical cannabis pharmacy shall pay a license fee that the department sets 
in accordance with Section 
63J-1-504
 in an amount that covers the department's 
cost of conducting the application review.
Section 5. Section 
4-41a-1101
 is amended to read:
4-41a-1101
. Operating requirements -- General.
(1)
(a)
A medical cannabis pharmacy shall operate:
(i)
at the physical address provided to the department under Section 
4-41a-1001
; and
(ii)
in accordance with the operating plan provided to the department under Section 
4-41a-1001
 and, if applicable, Section 
4-41a-1004
.
(b)
A medical cannabis pharmacy shall notify the department before a change in the 
medical cannabis pharmacy's physical address or operating plan.
(2)
An individual may not enter a medical cannabis pharmacy unless the individual:
(a)
is at least 18 years old or is an emancipated minor under Section 
80-7-105
; and
(b)
except as provided in Subsection 
(4)
:
(i)
possesses a valid:
(A)
medical cannabis pharmacy agent registration card;
(B)
pharmacy medical provider registration card; or
(C)
medical cannabis card;
(ii)
is an employee of the department performing an inspection under Section 
4-41a-1103
; or
(iii)
is another individual as the department provides.
(3)
A medical cannabis pharmacy may not employ an individual who is younger than 21 
years old.
(4)
Notwithstanding Subsection 
(2)(a)
(2)(b)
, a medical cannabis pharmacy may authorize 
an individual who is not a medical cannabis pharmacy agent or pharmacy medical 
provider to access the medical cannabis pharmacy if the medical cannabis pharmacy 
tracks and monitors the individual at all times while the individual is at the medical 
cannabis pharmacy and maintains a record of the individual's access.
(5)
A medical cannabis pharmacy shall operate in a facility that has:
(a)
a single, secure public entrance;
(b)
a security system with a backup power source that:
(i)
detects and records entry into the medical cannabis pharmacy; and
(ii)
provides notice of an unauthorized entry to law enforcement when the medical 
cannabis pharmacy is closed; and
(c)
a lock on each area where the medical cannabis pharmacy stores medical cannabis.
(6)
A medical cannabis pharmacy shall post, both clearly and conspicuously in the medical 
cannabis pharmacy, the limit on the purchase of cannabis described in Subsection 
4-41a-1102(2)
.
(7)
Except for an emergency situation described in Subsection 
26B-4-213(3)(b)
, a medical 
cannabis pharmacy may not allow any individual to consume cannabis on the property 
or premises of the medical cannabis pharmacy.
(8)
A medical cannabis pharmacy may not sell medical cannabis without first indicating on 
the medical cannabis label the name of the medical cannabis pharmacy.
(9)
(a)
Each medical cannabis pharmacy shall retain in the pharmacy's records the 
following information regarding each recommendation underlying a transaction:
(i)
the recommending medical provider's name, address, and telephone number;
(ii)
the patient's name and address;
(iii)
the date of issuance;
(iv)
directions of use and dosing guidelines or an indication that the recommending 
medical provider did not recommend specific directions of use or dosing 
guidelines; and
(v)
if the patient did not complete the transaction, the name of the medical cannabis 
cardholder who completed the transaction.
(b)
(i)
Except as provided in Subsection 
(9)(b)(iii)
, a medical cannabis pharmacy may 
not sell medical cannabis unless the medical cannabis has a label securely affixed 
to the container indicating the following minimum information:
(A)
the name, address, and telephone number of the medical cannabis pharmacy;
(B)
the unique identification number that the medical cannabis pharmacy assigns;
(C)
the date of the sale;
(D)
the name of the patient;
(E)
the name of the recommending medical provider who recommended the 
medical cannabis treatment;
(F)
directions for use and cautionary statements, if any;
(G)
the amount dispensed and the cannabinoid content;
(H)
the suggested use date;
(I)
for unprocessed cannabis flower, the legal use termination date; and
(J)
any other requirements that the department determines, in consultation with the 
Division of Professional Licensing and the Board of Pharmacy.
(ii)
A medical cannabis pharmacy is exempt from the requirement to provide the 
following information under Subsection 
(9)(b)(i)
 if the information is already 
provided on the product label that a cannabis production establishment affixes:
(A)
a unique identification number;
(B)
directions for use and cautionary statements;
(C)
amount and cannabinoid content; and
(D)
a suggested use date.
(iii)
If the size of a medical cannabis container does not allow sufficient space to 
include the labeling requirements described in Subsection 
(9)(b)(i)
, the medical 
cannabis pharmacy may provide the following information described in 
Subsection 
(9)(b)(i)
 on a supplemental label attached to the container or an 
informational enclosure that accompanies the container:
(A)
the cannabinoid content;
(B)
the suggested use date; and
(C)
any other requirements that the department determines.
(iv)
A medical cannabis pharmacy may sell medical cannabis to another medical 
cannabis pharmacy without a label described in Subsection 
(9)(b)(i)
.
(10)
A pharmacy medical provider or medical cannabis pharmacy agent shall:
(a)
upon receipt of an order from a recommending medical provider in accordance with 
Subsections 
26B-4-204(1)(b)
 and 
(c)
:
(i)
for a written order or an electronic order under circumstances that the department 
determines, contact the recommending medical provider or the recommending 
medical provider's office to verify the validity of the recommendation; and
(ii)
for an order that the pharmacy medical provider or medical cannabis pharmacy 
agent verifies under Subsection 
(10)(a)(i)
 or an electronic order that is not subject 
to verification under Subsection 
(10)(a)(i)
, enter the recommending medical 
provider's recommendation or renewal, including any associated directions of use, 
dosing guidelines, or caregiver indication, in the state electronic verification 
system;
(b)
in processing an order for a holder of a conditional medical cannabis card described 
in Subsection 
26B-4-213(1)(b)
 that appears irregular or suspicious in the judgment of 
the pharmacy medical provider or medical cannabis pharmacy agent, contact the 
recommending medical provider or the recommending medical provider's office to 
verify the validity of the recommendation before processing the cardholder's order;
(c)
unless the medical cannabis cardholder has had a consultation under Subsection 
26B-4-231(5)
, verbally offer to a medical cannabis cardholder at the time of a 
purchase of medical cannabis or a medical cannabis device, personal counseling with 
the pharmacy medical provider; and
(d)
provide a telephone number or website by which the cardholder may contact a 
pharmacy medical provider for counseling.
(11)
(a)
A medical cannabis pharmacy may create a medical cannabis disposal program 
that allows an individual to deposit unused or excess medical cannabis or cannabis 
residue from a medical cannabis device in a locked box or other secure receptacle 
within the medical cannabis pharmacy.
(b)
A medical cannabis pharmacy with a disposal program described in Subsection 
(11)(a)
 shall ensure that only a medical cannabis pharmacy agent or pharmacy 
medical provider can access deposited medical cannabis.
(c)
A medical cannabis pharmacy shall dispose of any deposited medical cannabis by:
(i)
rendering the deposited medical cannabis unusable and unrecognizable before 
transporting deposited medical cannabis from the medical cannabis pharmacy; and
(ii)
disposing of the deposited medical cannabis in accordance with:
(A)
federal and state law, rules, and regulations related to hazardous waste;
(B)
the Resource Conservation and Recovery Act, 42 U.S.C. Sec. 6991 et seq.;
(C)
Title 19, Chapter 6, Part 5, Solid Waste Management Act; and
(D)
other regulations that the department makes in accordance with Title 63G, 
Chapter 3, Utah Administrative Rulemaking Act.
(12)
A medical cannabis pharmacy:
(a)
shall employ a pharmacist who is licensed under Title 58, Chapter 17b, Pharmacy 
Practice Act, as a pharmacy medical provider;
(b)
may employ a physician who has the authority to write a prescription and is licensed 
under Title 58, Chapter 67, Utah Medical Practice Act, or Title 58, Chapter 68, Utah 
Osteopathic Medical Practice Act, as a pharmacy medical provider;
(c)
shall ensure that a pharmacy medical provider described in Subsection 
(12)(a)
 works 
onsite during all business hours;
(d)
shall designate one pharmacy medical provider described in Subsection 
(12)(a)
 as the 
pharmacist-in-charge to oversee the operation of and generally supervise the medical 
cannabis pharmacy;
(e)
shall allow the pharmacist-in-charge to determine which medical cannabis products 
the medical cannabis pharmacy maintains in the medical cannabis pharmacy's 
inventory;
(f)
for each medical cannabis product sold by the medical cannabis pharmacy, shall:
(i)
allow a medical cannabis cardholder located in the pharmacy to view the 
back 
fact 
panel of the product when requested; and
(ii)
beginning July 1, 2025, include a picture of the 
back
fact
 panel of the product on 
the medical cannabis pharmacy's website;
(g)
shall maintain a video surveillance system that:
(i)
tracks all handling of medical cannabis in the pharmacy;
(ii)
is tamper proof; and
(iii)
stores a video record for at least 45 days;
(h)
shall provide the department access to the video surveillance system upon request;
(i)
if a patient product information insert is available, shall provide a patient who 
purchases a medical cannabis product the medical cannabis product's patient product 
information insert using any of the following methods:
(i)
a physical document;
(ii)
an email message;
(iii)
a text message; or
(iv)
a quick response code; and
(j)
may not allow a recommending medical provider to recommend medical cannabis as 
part of an event that:
(i)
is a temporary gathering, market, clinic, or promotional event;
(ii)
operates in a temporary tent or structure; and
(iii)
is held within 500 feet of the medical cannabis pharmacy's property line.
(13)
The department shall establish by rule, in accordance with Title 63G, Chapter 3, Utah 
Administrative Rulemaking Act, protocols for a recall of cannabis and cannabis products 
by a medical cannabis pharmacy.
Section 6. Section 
4-41a-1106
 is amended to read:
4-41a-1106
. Medical cannabis pharmacy agent -- Registration.
(1)
An individual may not serve as a medical cannabis pharmacy agent of a medical 
cannabis pharmacy unless the department registers the individual as a medical cannabis 
pharmacy agent.
(2)
A recommending medical provider may not act as a medical cannabis pharmacy agent, 
have a financial or voting interest of 2% or greater in a medical cannabis pharmacy, or 
have the power to direct or cause the management or control of a medical cannabis 
pharmacy.
(3)
(a)
The department shall, within 15 days after the day on which the department 
receives a complete application from a medical cannabis pharmacy on behalf of a 
prospective medical cannabis pharmacy agent, register and issue a medical cannabis 
pharmacy agent registration card to the prospective agent if the medical cannabis 
pharmacy:
(i)
provides to the department:
(A)
the prospective agent's name and address;
(B)
the name and location of the licensed medical cannabis pharmacy where the 
prospective agent seeks to act as the medical cannabis pharmacy agent; and
(C)
the submission required under Subsection 
(3)(b)
; and
(ii)
pays a fee to the department in an amount that, subject to Subsection 
4-41a-104(5)
, 
the department sets in accordance with Section 
63J-1-504
.
(b)
Each prospective agent described in Subsection 
(3)(a)
 shall:
(i)
submit to the department:
(A)
a fingerprint card in a form acceptable to the Department of Public Safety; and
(B)
a signed waiver in accordance with Subsection 
53-10-108(4)
 acknowledging 
the registration of the prospective agent's fingerprints in the Federal Bureau of 
Investigation Next Generation Identification System's Rap Back Service; and
(ii)
consent to a fingerprint background check by:
(A)
the Bureau of Criminal Identification; and
(B)
the Federal Bureau of Investigation.
(c)
The Bureau of Criminal Identification shall:
(i)
check the fingerprints the prospective agent submits under Subsection 
(3)(b)
against the applicable state, regional, and national criminal records databases, 
including the Federal Bureau of Investigation Next Generation Identification 
System;
(ii)
report the results of the background check to the department;
(iii)
maintain a separate file of fingerprints that prospective agents submit under 
Subsection 
(3)(b)
 for search by future submissions to the local and regional 
criminal records databases, including latent prints;
(iv)
request that the fingerprints be retained in the Federal Bureau of Investigation 
Next Generation Identification System's Rap Back Service for search by future 
submissions to national criminal records databases, including the Next Generation 
Identification System and latent prints; and
(v)
establish a privacy risk mitigation strategy to ensure that the department only 
receives notifications for an individual with whom the department maintains an 
authorizing relationship.
(d)
The department shall:
(i)
assess an individual who submits fingerprints under Subsection 
(3)(b)
 a fee in an 
amount that the department sets in accordance with Section 
63J-1-504
 for the 
services that the Bureau of Criminal Identification or another authorized agency 
provides under this section; and
(ii)
remit the fee described in Subsection 
(3)(d)(i)
 to the Bureau of Criminal 
Identification.
(4)
A medical cannabis pharmacy agent shall comply with a certification standard that the 
department develops in collaboration with the Division of Professional Licensing and 
the Board of Pharmacy, or a third-party certification standard that the department 
designates by rule, in collaboration with the Division of Professional Licensing and the 
Board of Pharmacy and in accordance with Title 63G, Chapter 3, Utah Administrative 
Rulemaking Act.
(5)
The department shall ensure that the certification standard described in Subsection 
(4)
includes training in:
(a)
Utah medical cannabis law; and
(b)
medical cannabis pharmacy best practices.
(6)
The department 
may
shall
 revoke the medical cannabis pharmacy agent registration 
card of, or refuse to issue a medical cannabis pharmacy agent registration card to, an 
individual who:
(a)
violates the requirements of this chapter; or
(b)
is convicted under state or federal law of:
(i)
a felony within the preceding 10 years; or
(ii)
after December 3, 2018, a misdemeanor for drug distribution.
(7)
(a)
A medical cannabis pharmacy agent registration card expires two years after the 
day on which the department issues or renews the card.
(b)
A medical cannabis pharmacy agent may renew the agent's registration card if the 
agent:
(i)
is eligible for a medical cannabis pharmacy agent registration card under this 
section;
(ii)
certifies to the department in a renewal application that the information in 
Subsection 
(3)(a)
 is accurate or updates the information; and
(iii)
pays to the department a renewal fee in an amount that:
(A)
subject to Subsection 
4-41a-104(5)
, the department sets in accordance with 
Section 
63J-1-504
; and
(B)
may not exceed the cost of the relatively lower administrative burden of 
renewal in comparison to the original application process.
(8)
(a)
As a condition precedent to registration and renewal of a medical cannabis 
pharmacy agent registration card, a medical cannabis pharmacy agent shall:
(i)
complete at least one hour of continuing education regarding patient privacy and 
federal health information privacy laws that is offered by the department under 
Subsection (8)(b) or an accredited or approved continuing education provider that 
the department recognizes as offering continuing education appropriate for the 
medical cannabis pharmacy practice; and
(ii)
make a continuing education report to the department in accordance with a 
process that the department establishes by rule, in accordance with Title 63G, 
Chapter 3, Utah Administrative Rulemaking Act, and in collaboration with the 
Division of Professional Licensing and the Board of Pharmacy.
(b)
The department may, in consultation with the Division of Professional Licensing, 
develop the continuing education described in this Subsection (8).
(c)
The pharmacist-in-charge described in Section 
26B-4-219
 shall ensure that each 
medical cannabis pharmacy agent working in the medical cannabis pharmacy who 
has access to the state electronic verification system is in compliance with this 
Subsection (8).
(d)
A medical cannabis pharmacy agent may not access the electronic verification 
system following the termination of the medical cannabis pharmacy agent's 
employment.
(9)
(8)
A medical cannabis pharmacy shall:
(a)
maintain a list of employees that have a medical cannabis pharmacy agent 
registration card; and
(b)
provide the list to the department upon request.
Section 7. Section 
4-41a-1201
 is amended to read:
4-41a-1201
. Medical cannabis home delivery designation.
(1)
The department may designate a medical cannabis pharmacy as a home delivery 
medical cannabis pharmacy if the department determines that the medical cannabis 
pharmacy's operating plan demonstrates the functional and technical ability to:
(a)
safely conduct transactions for medical cannabis shipments;
 and
(b)
accept electronic medical cannabis orders
; and
.
(c)
accept payments through:
(i)
a payment provider that the Division of Finance approves, in consultation with 
the state treasurer, in accordance with Section 
26-61a-603
; or
(ii)
a financial institution in accordance with Subsection 
26-61a-603(4)
.
(2)
An applicant seeking a designation as a home delivery medical cannabis pharmacy shall 
identify in the applicant's operating plan any information relevant to the department's 
evaluation described in Subsection 
(1)
, including:
(a)
the name and contact information of the payment provider;
(b)
the nature of the relationship between the prospective licensee and the payment 
provider;
(c)
the processes 
of the following
followed
 to safely and reliably conduct transactions 
for medical cannabis shipments
:
.
(i)
the prospective licensee; and
(ii)
the electronic payment provider or the financial institution described in 
Subsection 
(1)(c)
; and
(d)
the ability of the licensee to comply with the department's rules regarding the secure 
transportation and delivery of medical cannabis to a medical cannabis cardholder.
(3)
Notwithstanding any county or municipal ordinance, a medical cannabis pharmacy that 
the department designates as a home delivery medical cannabis pharmacy may deliver 
medical cannabis shipments in accordance with this part.
Section 8. Section 
4-41a-1204
 is amended to read:
4-41a-1204
. Medical cannabis courier agent -- Background check -- Registration 
card -- Rebuttable presumption.
(1)
An individual may not serve as a medical cannabis courier agent unless the department 
registers the individual as a medical cannabis courier agent.
(2)
(a)
The department shall, within 15 days after the day on which the department 
receives a complete application from a medical cannabis courier on behalf of a 
medical cannabis courier agent, register and issue a medical cannabis courier agent 
registration card to the prospective agent if the medical cannabis courier:
(i)
provides to the department:
(A)
the prospective agent's name and address;
(B)
the name and address of the medical cannabis courier;
(C)
the name and address of each home delivery medical cannabis pharmacy with 
which the medical cannabis courier contracts to deliver medical cannabis 
shipments; and
(D)
the submission required under Subsection 
(2)(b)
;
(ii)
as reported under Subsection 
(2)(c)
, has not been convicted under state or federal 
law of:
(A)
a felony; or
(B)
after December 3, 2018, a misdemeanor for drug distribution; and
(iii)
pays the department a fee in an amount that, subject to Subsection 
4-41a-104(5)
, 
the department sets in accordance with Section 
63J-1-504
.
(b)
Each prospective agent described in Subsection 
(2)(a)
 shall:
(i)
submit to the department:
(A)
a fingerprint card in a form acceptable to the Department of Public Safety; and
(B)
a signed waiver in accordance with Subsection 
53-10-108(4)
 acknowledging 
the registration of the prospective agent's fingerprints in the Federal Bureau of 
Investigation Next Generation Identification System's Rap Back Service; and
(ii)
consent to a fingerprint background check by:
(A)
the Bureau of Criminal Identification; and
(B)
the Federal Bureau of Investigation.
(c)
The Bureau of Criminal Identification shall:
(i)
check the fingerprints the prospective agent submits under Subsection 
(2)(b)
against the applicable state, regional, and national criminal records databases, 
including the Federal Bureau of Investigation Next Generation Identification 
System;
(ii)
report the results of the background check to the department;
(iii)
maintain a separate file of fingerprints that prospective agents submit under 
Subsection 
(2)(b)
 for search by future submissions to the local and regional 
criminal records databases, including latent prints;
(iv)
request that the fingerprints be retained in the Federal Bureau of Investigation 
Next Generation Identification System's Rap Back Service for search by future 
submissions to national criminal records databases, including the Next Generation 
Identification System and latent prints; and
(v)
establish a privacy risk mitigation strategy to ensure that the department only 
receives notifications for an individual with whom the department maintains an 
authorizing relationship.
(d)
The department shall:
(i)
assess an individual who submits fingerprints under Subsection 
(2)(b)
 a fee in an 
amount that the department sets in accordance with Section 
63J-1-504
 for the 
services that the Bureau of Criminal Identification or another authorized agency 
provides under this section; and
(ii)
remit the fee described in Subsection 
(2)(d)(i)
 to the Bureau of Criminal 
Identification.
(3)
(a)
A medical cannabis courier agent shall comply with a certification standard that 
the department develops, in collaboration with the Division of Professional Licensing 
and the Board of Pharmacy, or a third-party certification standard that the department 
designates by rule in collaboration with the Division of Professional Licensing and 
the Board of Pharmacy and in accordance with 
Title 63G, Chapter 3, Utah 
Administrative Rulemaking Act
.
(b)
The department shall ensure that the certification standard described in Subsection 
(3)(a)
 includes training in:
(i)
Utah medical cannabis law;
(ii)
the medical cannabis shipment process; and
(iii)
medical cannabis courier agent best practices.
(4)
(a)
A medical cannabis courier agent registration card expires two years after the day 
on which the department issues or renews the card.
(b)
A medical cannabis courier agent may renew the agent's registration card if the agent:
(i)
is eligible for a medical cannabis courier agent registration card under this section;
(ii)
certifies to the department in a renewal application that the information in 
Subsection 
(2)(a)
 is accurate or updates the information; and
(iii)
pays to the department a renewal fee in an amount that:
(A)
subject to Subsection 
4-41a-104(5)
, the department sets in accordance with 
Section 
63J-1-504
; and
(B)
may not exceed the cost of the relatively lower administrative burden of 
renewal in comparison to the original application process.
(5)
The department 
may
shall
 revoke or refuse to issue or renew the medical cannabis 
courier agent registration card of an individual who:
(a)
violates the requirements of this chapter; or
(b)
is convicted under state or federal law of:
(i)
a felony within the preceding 10 years; or
(ii)
after December 3, 2018, a misdemeanor for drug distribution.
(6)
A medical cannabis courier agent whom the department has registered under this section 
shall carry the agent's medical cannabis courier agent registration card with the agent at 
all times when:
(a)
the agent is on the premises of the medical cannabis courier, a medical cannabis 
pharmacy, or a delivery address; and
(b)
the agent is handling a medical cannabis shipment.
(7)
If a medical cannabis courier agent handling a medical cannabis shipment possesses the 
shipment in compliance with Subsection 
(6)
:
(a)
there is a rebuttable presumption that the agent possesses the shipment legally; and
(b)
there is no probable cause, based solely on the agent's possession of the medical 
cannabis shipment that the agent is engaging in illegal activity.
(8)
(a)
A medical cannabis courier agent who violates Subsection 
(6)
 is:
(i)
guilty of an infraction; and
(ii)
subject to a $100 fine.
(b)
An individual who is guilty of a violation described in Subsection 
(8)(a)
 is not guilty 
of a violation of 
Title 58, Chapter 37, Utah Controlled Substances Act
, for the 
conduct underlying the violation described in Subsection 
(8)(a)
.
(9)
A medical cannabis courier shall:
(a)
maintain a list of employees who have a medical cannabis courier agent card; and
(b)
provide the list to the department upon request.
Section 9. Section 
4-41a-1205
 is amended to read:
4-41a-1205
. Home delivery of medical cannabis shipments.
(1)
An individual may not receive and a medical cannabis pharmacy agent or a medical 
cannabis courier agent may not deliver a medical cannabis shipment from a home 
delivery medical cannabis pharmacy unless:
(a)
the individual receiving the shipment presents:
(i)
a government issued photo identification; and
(ii)
(A)
a valid medical cannabis card under the same name that appears on the 
government issued photo identification; or
(B)
for a facility that a medical cannabis cardholder has designated as a caregiver 
under Subsection 
26B-4-214(1)(b)
, evidence of the facility caregiver 
designation; and
(b)
the delivery occurs at:
(i)
the delivery address that is on file in the state electronic verification system; or
(ii)
the facility that the medical cannabis cardholder has designated as a caregiver 
under Subsection 
26B-4-214(1)(b)
.
(2)
(a)
A medical cannabis pharmacy agent may not deliver a medical cannabis shipment 
on behalf of a home delivery medical cannabis pharmacy unless the medical cannabis 
pharmacy agent is currently employed by the home delivery medical cannabis 
pharmacy.
(b)
A medical cannabis courier agent may not deliver a medical cannabis shipment on 
behalf of a medical cannabis courier unless the medical cannabis courier agent is 
currently employed by the medical cannabis courier.
(c)
Before a medical cannabis pharmacy agent or a medical cannabis courier agent 
distributes a medical cannabis shipment to a medical cannabis cardholder, the agent 
shall:
(i)
verify the shipment information using the state electronic verification system;
(ii)
ensure that the individual satisfies the identification requirements in Subsection 
(1)
;
(iii)
verify that payment is complete; and
(iv)
record the completion of the shipment transaction in a manner such that the 
delivery of the shipment will later be recorded within a reasonable period in the 
electronic verification system.
(3)
The
When delivering a medical cannabis shipment, a home delivery medical cannabis 
pharmacy or
 medical cannabis courier shall:
(a)
(i)
store each medical cannabis shipment in a secure manner until the recipient 
medical cannabis cardholder receives the shipment or the medical cannabis 
courier returns the shipment to the home delivery medical cannabis pharmacy in 
accordance with Subsection 
(4)
; 
and
(ii)
(b)
use adequate storage or shipping containers and shipping processes to ensure 
medical cannabis stability and potency and appropriate storage temperatures 
throughout delivery;
(c)
use shipping containers sealed in a manner to detect evidence of opening or 
tampering;
(d)
ensure that only a
 home delivery medical cannabis pharmacy agent or
 medical 
cannabis courier agent is able to access the medical cannabis shipment until the 
recipient medical cannabis cardholder receives the shipment;
(b)
(e)
return any undelivered medical cannabis shipment to the home delivery medical 
cannabis pharmacy, in accordance with Subsection 
(4)
,
 after the medical cannabis 
courier has possessed the shipment for 10 business days
 within 14 days from the day 
the medical cannabis shipment was shipped
; and
(c)
(f)
return any medical cannabis shipment to the home delivery medical cannabis 
pharmacy, in accordance with Subsection 
(4)
, if a medical cannabis cardholder 
refuses to accept the shipment.
(4)
(a)
If a medical cannabis courier or home delivery medical cannabis pharmacy agent 
returns an undelivered medical cannabis shipment 
that remains unopened, the home 
delivery medical cannabis pharmacy may repackage or otherwise reuse the shipment
before the home delivery medical cannabis pharmacy may repackage the medical 
cannabis in the returned medical cannabis shipment, the pharmacist at the home 
delivery medical cannabis pharmacy shall:
(i)
verify that the medical cannabis was returned to the original home delivery 
medical cannabis pharmacy within 14 days from the day the medical cannabis was 
shipped; and
(ii)
determine in the pharmacist's clinical judgment that the medical cannabis's 
integrity is intact and the security of the drug packaging has not been compromised
.
(b)
If a medical cannabis courier or home delivery medical cannabis pharmacy agent 
returns an undelivered or refused medical cannabis shipment under Subsection 
(3)
that appears to be opened in any way
For returned medical cannabis described in 
Subsection 
(4)(a)
 that a pharmacist deems does not comply with Subsection 
(4)(a)(i)
or 
(ii)
, the home delivery medical cannabis pharmacy shall dispose of the 
shipment
medical cannabis
 by:
(i)
rendering the 
shipment
medical cannabis
 unusable and unrecognizable before 
transporting the 
shipment
medical cannabis
 from the home delivery medical 
cannabis pharmacy; and
(ii)
disposing of the 
shipment
medical cannabis
 in accordance with:
(A)
federal and state laws, rules, and regulations related to hazardous waste;
(B)
the Resource Conservation and Recovery Act, 42 U.S.C. Sec. 6991 et seq.;
(C)
Title 19, Chapter 6, Part 5, Solid Waste Management Act
; and
(D)
other regulations that the department makes in accordance with 
Title 63G, 
Chapter 3, Utah Administrative Rulemaking Act
.
Section 10. Section 
26B-1-310
 is amended to read:
26B-1-310
. Qualified Patient Enterprise Fund -- Creation -- Revenue neutrality 
-- Uniform fee.
(1)
There is created an enterprise fund known as the "Qualified Patient Enterprise Fund."
(2)
The fund created in this section is funded from:
(a)
money the department deposits into the fund under 
Chapter 4, Part 2, Cannabinoid 
Research and Medical Cannabis
;
(b)
appropriations the Legislature makes to the fund; and
(c)
the interest described in Subsection 
(3)
.
(3)
Interest earned on the fund shall be deposited into the fund.
(4)
Money deposited into the fund may only be used by:
(a)
the department to accomplish the department's responsibilities described in 
Chapter 
4, Part 2, Cannabinoid Research and Medical Cannabis
; 
(b)
the Center for Medical Cannabis Research created in Section 
53H-4-206
 to 
accomplish the Center for Medical Cannabis Research's responsibilities; and
(c)
the Department of Agriculture and Food for the one time purchase of equipment to 
meet the requirements described in Section 
4-41a-204.1
.
if there is remaining money 
in the fund balance on June 30 of each fiscal year after all other financial obligations 
under this Subsection 
(4)
 are met, the department shall provide up to $300,000 for 
expenditure the next fiscal year to the non
profit contracting entity described in S
ection 
26B-4-248
.
(5)
The department shall set fees authorized under 
Chapter 4, Part 2, Cannabinoid Research 
and Medical Cannabis
, in amounts that the department anticipates are necessary, in total, 
to cover the department's cost to implement 
Chapter 4, Part 2, Cannabinoid Research 
and Medical Cannabis
.
(6)
The department may impose a uniform fee on each medical cannabis transaction in a 
medical cannabis pharmacy in an amount that, subject to Subsection 
(5)
, the department 
sets in accordance with Section 
63J-1-504
.
Section 11. Section 
26B-1-421
 is amended to read:
26B-1-421
. Compassionate Use Board.
(1)
The definitions in Section 
26B-4-201
 apply to this section.
(2)
(a)
The department shall establish a Compassionate Use Board consisting of:
(i)
seven 
qualified
recommending
 medical providers that the executive director 
appoints with the advice and consent of the Senate:
(A)
who are knowledgeable about the medicinal use of cannabis;
(B)
who are physicians licensed under Title 58, Chapter 67, Utah Medical Practice 
Act, or Title 58, Chapter 68, Utah Osteopathic Medical Practice Act; and
(C)
who are board certified by the American Board of Medical Specialties or an 
American Osteopathic Association Specialty Certifying Board in the specialty 
of neurology, pain medicine and pain management, medical oncology, 
psychiatry, infectious disease, internal medicine, pediatrics, family medicine, 
or gastroenterology; and
(ii)
as a nonvoting member and the chair of the Compassionate Use Board, the 
executive director or the director's designee.
(b)
In appointing the seven 
qualified
recommending
 medical providers described in 
Subsection 
(2)(a)
(2)(a)(i)
, the executive director shall ensure that at least two have a 
board certification in pediatrics.
(3)
(a)
Of the members of the Compassionate Use Board that the executive director first 
appoints:
(i)
three shall serve an initial term of two years; and
(ii)
the remaining members shall serve an initial term of four years.
(b)
After an initial term described in Subsection 
(3)(a)
 expires:
(i)
each term is four years; and
(ii)
each board member is eligible for reappointment.
(c)
A member of the Compassionate Use Board may serve until a successor is appointed.
(d)
Four members constitute a quorum of the Compassionate Use Board.
(4)
A member of the Compassionate Use Board may receive:
(a)
notwithstanding Section 
63A-3-106
, compensation or benefits for the member's 
service; and
(b)
travel expenses in accordance with Section 
63A-3-107
 and rules made by the 
Division of Finance in accordance with Section 
63A-3-107
.
(5)
The Compassionate Use Board shall:
(a)
review and recommend for department approval a petition to the board regarding an 
individual described in Subsection 
26B-4-213(2)(a)
, a minor described in Subsection 
26B-4-213(2)(c)
, or an individual who is not otherwise qualified to receive a medical 
cannabis card to obtain a medical cannabis card for compassionate use, for the 
standard or a reduced period of validity, if:
(i)
for an individual who is not otherwise qualified to receive a medical cannabis 
card, the individual's recommending medical provider is actively treating the 
individual for an intractable condition that:
(A)
substantially impairs the individual's quality of life; and
(B)
has not, in the recommending medical provider's professional opinion, 
adequately responded to conventional treatments;
(ii)
the recommending medical provider:
(A)
recommends that the individual or minor be allowed to use medical cannabis; 
and
(B)
provides a letter, relevant treatment history, and notes or copies of progress 
notes describing relevant treatment history including rationale for considering 
the use of medical cannabis; and
(iii)
the Compassionate Use Board determines that:
(A)
the recommendation of the individual's recommending medical provider is 
justified; and
(B)
based on available information, it may be in the best interests of the individual 
to allow the use of medical cannabis;
(b)
when a recommending medical provider recommends that an individual described in 
Subsection 
26B-4-213(2)(a)(i)(B)
 or a minor described in Subsection 
26B-4-213(2)(c)
be allowed to use a medical cannabis device or medical cannabis to vaporize a 
medical cannabis treatment, review and approve or deny the use of the medical 
cannabis device or medical cannabis;
(c)
unless no petitions are pending:
(i)
meet to receive or review compassionate use petitions at least quarterly; and
(ii)
if there are more petitions than the board can receive or review during the board's 
regular schedule, as often as necessary;
(d)
except as provided in Subsection 
(6)
, complete a review of each petition and 
recommend to the department approval or denial of the applicant for qualification for 
a medical cannabis card within 90 days after the day on which the board received the 
petition; and
(e)
consult with the department regarding the criteria described in Subsection 
(6)
.
(6)
The department shall make rules, in consultation with the Compassionate Use Board 
and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to 
establish a process and criteria for a petition to the board to automatically qualify for 
expedited final review and approval or denial by the department in cases where, in the 
determination of the department and the board:
(a)
time is of the essence;
(b)
engaging the full review process would be unreasonable in light of the petitioner's 
physical condition; and
(c)
sufficient factors are present regarding the petitioner's safety.
(7)
(a)
(i)
The department shall review:
(A)
any compassionate use for which the Compassionate Use Board recommends 
approval under Subsection 
(5)(d)
 to determine whether the board properly 
exercised the board's discretion under this section; and
(B)
any expedited petitions the department receives under the process described in 
Subsection 
(6)
.
(ii)
If the department determines that the Compassionate Use Board properly 
exercised the board's discretion in recommending approval under Subsection 
(5)(d)
or that the expedited petition merits approval based on the criteria established in 
accordance with Subsection 
(6)
, the department shall:
(A)
issue the relevant medical cannabis card; and
(B)
provide for the renewal of the medical cannabis card in accordance with the 
recommendation of the recommending medical provider described in 
Subsection 
(5)(a)
.
(b)
If the Compassionate Use Board recommends denial under Subsection 
(5)(d)
, the 
individual seeking to obtain a medical cannabis card may petition the department to 
review the board's decision.
(c)
In reviewing the Compassionate Use Board's recommendation for approval or denial 
under Subsection 
(5)(d)
 in accordance with this Subsection 
(7)
, the department shall 
presume the board properly exercised the board's discretion unless the department 
determines that the board's recommendation was arbitrary or capricious.
(8)
Any individually identifiable health information contained in a petition that the 
Compassionate Use Board or department receives under this section is a protected 
record in accordance with Title 63G, Chapter 2, Government Records Access and 
Management Act.
(9)
The Compassionate Use Board shall annually report the board's activity to the advisory 
board.
Section 12. Section 
26B-4-201
 is amended to read:
26B-4-201
. Definitions.
As used in this part:
(1)
"Active tetrahydrocannabinol" means THC, any THC analog, and 
tetrahydrocannabinolic acid.
(2)
"Administration of criminal justice" means the performance of detection, apprehension, 
detention, pretrial release, post-trial release, prosecution, and adjudication.
(3)
"Advertise" means information provided by a person in any medium:
(a)
to the public; and
(b)
that is not age restricted to an individual who is at least 21 years old.
(4)
"Advisory board" means the Medical Cannabis Policy Advisory Board created in 
Section 
26B-1-435
.
(5)
"Cannabis" means marijuana.
(6)
"Cannabis processing facility" means the same as that term is defined in Section 
4-41a-102
.
(7)
"Cannabis product" means a product that:
(a)
is intended for human use; and
(b)
contains cannabis or any tetrahydrocannabinol or THC analog in a total 
concentration of 0.3% or greater on a dry weight basis.
(8)
"Cannabis production establishment" means the same as that term is defined in Section 
4-41a-102
.
(9)
"Cannabis production establishment agent" means the same as that term is defined in 
Section 
4-41a-102
.
(10)
"Cannabis production establishment agent registration card" means the same as that 
term is defined in Section 
4-41a-102
.
(11)
"Conditional medical cannabis card" means an electronic medical cannabis card that 
the department issues in accordance with Subsection 
26B-4-213(1)(b)
 to allow an 
applicant for a medical cannabis card to access medical cannabis during the department's 
review of the application.
(12)
"Controlled substance database" means the controlled substance database created in 
Section 
58-37f-201
.
(13)
"Delivery address" means the same as that term is defined in Section 
4-41a-102
.
(14)
"Department" means the Department of Health and Human Services.
(15)
"Designated caregiver" means:
(a)
an individual:
(i)
whom an individual with a medical cannabis patient card or a medical cannabis 
guardian card designates as the patient's caregiver; and
(ii)
who registers with the department under Section 
26B-4-214
; or
(b)
(i)
a facility that an individual designates as a designated caregiver in accordance 
with Subsection 
26B-4-214(1)(b)
; or
(ii)
an assigned employee of the facility described in Subsection 
26B-4-214(1)(b)(ii)
.
(16)
"Directions of use" means recommended routes of administration for a medical 
cannabis treatment and suggested usage guidelines.
(17)
"Dosing guidelines" means a quantity range and frequency of administration for a 
recommended treatment of medical cannabis.
(18)
"Government issued photo identification" means any of the following forms of 
identification:
(a)
a valid state-issued driver license or identification card;
(b)
a valid United States federal-issued photo identification, including:
(i)
a United States passport;
(ii)
a United States passport card;
(iii)
a United States military identification card; or
(iv)
a permanent resident card or alien registration receipt card; 
or
(c)
a foreign passport
.
; or
(d)
a tribal government-issued photo identification.
(19)
"Home delivery medical cannabis pharmacy" means a medical cannabis pharmacy that 
the department authorizes, as part of the pharmacy's license, to deliver medical cannabis 
shipments to a delivery address to fulfill electronic orders.
(20)
"Incapacitated" means the same as that term is defined in Section 
75-1-201
.
(20)
(21)
"Inventory control system" means the system described in Section 
4-41a-103
.
(21)
(22)
"Legal dosage limit" means an amount that:
(a)
is sufficient to provide 30 days of treatment based on the dosing guidelines that the 
relevant recommending medical provider or pharmacy medical provider, in 
accordance with Subsection 
26B-4-231(5)
, recommends; and
(b)
may not exceed:
(i)
for unprocessed cannabis in a medicinal dosage form, 113 grams by weight; and
(ii)
for a cannabis product in a medicinal dosage form, a quantity that contains, in 
total, greater than 20 grams of active tetrahydrocannabinol.
(22)
(23)
"Legal use termination date" means a date on the label of a container of 
unprocessed cannabis flower:
(a)
that is 60 days after the date of purchase of the cannabis; and
(b)
after which, the cannabis is no longer in a medicinal dosage form outside of the 
primary residence of the relevant medical cannabis patient cardholder.
(23)
(24)
"Marijuana" means the same as that term is defined in Section 
58-37-2
.
(24)
(25)
"Medical cannabis" or "medical cannabis product" means cannabis in a 
medicinal dosage form or a cannabis product in a medicinal dosage form.
(25)
(26)
"Medical cannabis card" means a medical cannabis patient card, a medical 
cannabis guardian card, a medical cannabis caregiver card, or a conditional medical 
cannabis card.
(26)
(27)
"Medical cannabis cardholder" means:
(a)
a holder of a medical cannabis card; or
(b)
a facility or assigned employee, described in Subsection 
(15)(b)
, only:
(i)
within the scope of the facility's or assigned employee's performance of the role of 
a medical cannabis patient cardholder's caregiver designation under Subsection 
26B-4-214(1)(b)
; and
(ii)
while in possession of documentation that establishes:
(A)
a caregiver designation described in Subsection 
26B-4-214(1)(b)
;
(B)
the identity of the individual presenting the documentation; and
(C)
the relation of the individual presenting the documentation to the caregiver 
designation.
(27)
(28)
"Medical cannabis caregiver card" means an electronic document that a 
cardholder may print or store on an electronic device or a physical card or document that:
(a)
the department issues to an individual whom a medical cannabis patient cardholder 
or a medical cannabis guardian cardholder designates as a designated caregiver; and
(b)
is connected to the electronic verification system.
(28)
(29)
"Medical cannabis courier" means the same as that term is defined in Section 
4-41a-102
.
(29)
(30)
(a)
"Medical cannabis device" means a device that an individual uses to ingest 
or inhale medical cannabis.
(b)
"Medical cannabis device" does not include a device that:
(i)
facilitates cannabis combustion; or
(ii)
an individual uses to ingest substances other than cannabis.
(30)
(31)
"Medical cannabis guardian card" means an electronic document that a 
cardholder may print or store on an electronic device or a physical card or document that:
(a)
the department issues to the parent or legal guardian of a minor 
with a qualifying 
condition
or legal guardian of an incapacitated adult
; and
(b)
is connected to the electronic verification system.
(31)
(32)
"Medical cannabis patient card" means an electronic document that a cardholder 
may print or store on an electronic device or a physical card or document that:
(a)
the department issues to an individual with a qualifying condition; and
(b)
is connected to the electronic verification system.
(32)
(33)
"Medical cannabis pharmacy" means a person that:
(a)
(i)
acquires or intends to acquire medical cannabis from a cannabis processing 
facility or another medical cannabis pharmacy or a medical cannabis device; or
(ii)
possesses medical cannabis or a medical cannabis device; and
(b)
sells or intends to sell medical cannabis or a medical cannabis device to a medical 
cannabis cardholder.
(33)
(34)
"Medical cannabis pharmacy agent" means an individual who holds a valid 
medical cannabis pharmacy agent registration card issued by the department.
(34)
(35)
"Medical cannabis pharmacy agent registration card" means a registration card 
issued by the department that authorizes an individual to act as a medical cannabis 
pharmacy agent.
(35)
(36)
"Medical cannabis shipment" means the same as that term is defined in Section 
4-41a-102
.
(36)
(37)
"Medical cannabis treatment" means medical cannabis or a medical cannabis 
device.
(37)
(38)
(a)
"Medicinal dosage form" means:
(i)
for processed medical cannabis, the following with a specific and consistent 
cannabinoid content:
(A)
a tablet;
(B)
a capsule;
(C)
a concentrated liquid or viscous oil;
(D)
a liquid suspension that does not exceed 30 milliliters;
(E)
a topical preparation;
(F)
a transdermal preparation;
(G)
a sublingual preparation;
(H)
a gelatinous cube, gelatinous rectangular cuboid, or lozenge in a cube or 
rectangular cuboid shape;
(I)
a resin or wax; 
(J)
an aerosol; 
(K)
a suppository preparation; or
(L)
a soft or hard confection that is a uniform rectangular cuboid or uniform 
spherical shape, is homogeneous in color and texture, and each piece is a single 
serving; or
(ii)
for unprocessed cannabis flower, a container described in Section 
4-41a-602
 that:
(A)
contains cannabis flower in a quantity that varies by no more than 10% from 
the stated weight at the time of packaging;
(B)
at any time the medical cannabis cardholder transports or possesses the 
container in public, is contained within an opaque bag or box
 that the medical 
cannabis pharmacy provides
; and
(C)
is labeled with the container's content and weight, the date of purchase, the 
legal use termination date, and a barcode that provides information connected 
to an inventory control system.
(b)
"Medicinal dosage form" includes a portion of unprocessed cannabis flower that:
(i)
the medical cannabis cardholder has recently removed from the container 
described in Subsection 
(37)(a)(ii)
(38)(a)(ii)
 for use; and
(ii)
does not exceed the quantity described in Subsection 
(37)(a)(ii)
(38)(a)(ii)
.
(c)
"Medicinal dosage form" does not include:
(i)
any unprocessed cannabis flower outside of the container described in Subsection 
(37)(a)(ii)
(38)(a)(ii)
, except as provided in Subsection 
(37)(b)
(38)(b)
;
(ii)
any unprocessed cannabis flower in a container described in Subsection 
(37)(a)(ii)
(38)(a)(ii)
 after the legal use termination date;
(iii)
a process of vaporizing and inhaling concentrated cannabis by placing the 
cannabis on a nail or other metal object that is heated by a flame, including a 
blowtorch;
(iv)
a liquid suspension that is branded as a beverage;
(v)
a substance described in Subsection 
(37)(a)(i)
(38)(a)(i)
 or 
(ii)
 if the substance is 
not measured in grams, milligrams, or milliliters; or
(vi)
a substance that contains or is covered to any degree with chocolate.
(38)
(39)
"Nonresident patient" means an individual who:
(a)
is not a resident of Utah or has been a resident of Utah for less than 45 days;
(b)
has a currently valid medical cannabis card or the equivalent of a medical cannabis 
card under the laws of another state, district, territory, commonwealth, or insular 
possession of the United States; and
(c)
has been diagnosed with a qualifying condition as described in Section 
26B-4-203
.
(39)
(40)
"Patient product information insert" means a single page document or webpage 
that contains information about a medical cannabis product regarding:
(a)
how to use the product;
(b)
common side effects;
(c)
serious side effects;
(d)
dosage;
(e)
contraindications;
(f)
safe storage;
(g)
information on when a product should not be used; and
(h)
other information the department deems appropriate in consultation with the 
cannabis processing facility that created the product.
(40)
(41)
"Pharmacy medical provider" means the medical provider required to be on site 
at a medical cannabis pharmacy under Section 
26B-4-219
.
(41)
(42)
"Provisional patient card" means a card that:
(a)
the department issues to a minor 
with a qualifying condition
or incapacitated adult
for whom:
(i)
a recommending medical provider has recommended a medical cannabis 
treatment; and
(ii)
the department issues a medical cannabis guardian card to the minor's parent or 
legal guardian
 or the incapacitated adult's legal guardian
; and
(b)
is connected to the electronic verification system.
(42)
(43)
"Qualified Patient Enterprise Fund" means the enterprise fund created in Section 
26B-1-310
.
(43)
(44)
"Qualifying condition" means a condition described in Section 
26B-4-203
.
(44)
(45)
"Recommend" or "recommendation" means, for a recommending medical 
provider, the act of suggesting the use of medical cannabis treatment, which:
(a)
certifies the patient's eligibility for a medical cannabis card; and
(b)
may include, at the recommending medical provider's discretion, directions of use, 
with or without dosing guidelines.
(45)
(46)
"Recommending medical provider" means an individual who:
(a)
meets the recommending qualifications;
(b)
completes four hours of continuing medical education specific to medical cannabis 
through formal or informal sources; and
(c)
every two years, provides an acknowledgment to the department that the individual 
completed four hours of continuing medical education.
(46)
(47)
"Recommending qualifications" means that an individual:
(a)
(i)
has the authority to write a prescription;
(ii)
is licensed to prescribe a controlled substance under Title 58, Chapter 37, Utah 
Controlled Substances Act; and
(iii)
possesses the authority, in accordance with the individual's scope of practice, to 
prescribe a Schedule II controlled substance; and
(b)
is licensed as:
(i)
a podiatrist under Title 58, Chapter 5a, Podiatric Physician Licensing Act;
(ii)
an advanced practice registered nurse under Title 58, Chapter 31b, Nurse Practice 
Act;
(iii)
a physician under Title 58, Chapter 67, Utah Medical Practice Act, or Title 58, 
Chapter 68, Utah Osteopathic Medical Practice Act; or
(iv)
a physician assistant under Title 58, Chapter 70a, Utah Physician Assistant Act.
(47)
(48)
"State electronic verification system" means the system described in Section 
26B-4-202
.
(48)
(49)
"Targeted marketing" means the promotion by a recommending medical 
provider, medical clinic, or medical office that employs a recommending medical 
provider of a medical cannabis recommendation service using any of the following 
methods:
(a)
electronic communication to an individual who is at least 21 years old and has 
requested to receive promotional information;
(b)
an in-person marketing event that is held in an area where only an individual who is 
at least 21 years old may access the event;
(c)
other marketing material that is physically or digitally displayed in the office of the 
medical clinic or office that employs a recommending medical provider; or
(d)
a leaflet that a recommending medical provider, medical clinic, or medical office that 
employs a recommending medical provider shares with an individual who is at least 
21 years old.
(49)
(50)
"Tetrahydrocannabinol" or "THC" means a substance derived from cannabis or a 
synthetic equivalent as described in Subsection 
58-37-4(2)(a)(iii)(AA)
.
(50)
(51)
"THC analog" means the same as that term is defined in Section 
4-41-102
.
Section 13. Section 
26B-4-202
 is amended to read:
26B-4-202
. Electronic verification system.
(1)
The Department of Agriculture and Food, the department, the Department of Public 
Safety, and the Division of Technology Services shall:
(a)
enter into a memorandum of understanding in order to determine the function and 
operation of the state electronic verification system in accordance with Subsection 
(2)
;
(b)
coordinate with the Division of Purchasing
 and General Services
, under Title 63G, 
Chapter 6a, Utah Procurement Code, to develop a request for proposals for a 
third-party provider to develop and maintain the state electronic verification system 
in coordination with the Division of Technology Services; and
(c)
select a third-party provider who:
(i)
meets the requirements contained in the request for proposals issued under 
Subsection 
(1)(b)
; and
(ii)
may not have any commercial or ownership interest in a cannabis production 
establishment or a medical cannabis pharmacy.
(2)
The Department of Agriculture and Food, the department, the Department of Public 
Safety, and the Division of Technology Services shall ensure that the state electronic 
verification system described in Subsection 
(1)
:
(a)
allows an individual to apply for a medical cannabis patient card or, if applicable, a 
medical cannabis guardian card, provided that the card may not become active until:
(i)
the relevant recommending medical provider completes the associated medical 
cannabis recommendation; or
(ii)
the medical cannabis pharmacy completes the recording described in 
Subsection 
(2)(d)
Subsections 
(2)(d)(ii)
 and (iii)
;
(b)
allows an individual to apply to renew a medical cannabis patient card or a medical 
cannabis guardian card in accordance with Section 
26B-4-213
;
(c)
allows a recommending medical provider, or an employee described in Subsection 
(3)
acting on behalf of the recommending medical provider, to:
(i)
access dispensing and card status information regarding a patient:
(A)
with whom the recommending medical provider has a provider-patient 
relationship; and
(B)
for whom the recommending medical provider has recommended or is 
considering recommending a medical cannabis card;
(ii)
electronically recommend treatment with medical cannabis and optionally 
recommend dosing guidelines;
(iii)
electronically renew a recommendation to a medical cannabis patient cardholder 
or medical cannabis guardian cardholder:
(A)
using telehealth services, for the recommending medical provider who 
originally recommended a medical cannabis treatment during a face-to-face 
visit with the patient; or
(B)
during a face-to-face visit with the patient, for a recommending medical 
provider who did not originally recommend the medical cannabis treatment 
during a face-to-face visit; and
(iv)
submit an initial application, renewal application, or application payment on 
behalf of an individual applying for any of the following:
(A)
a medical cannabis patient card;
(B)
a medical cannabis guardian card; or
(C)
a medical cannabis caregiver card;
(d)
allows a medical cannabis pharmacy medical provider or medical cannabis pharmacy 
agent, in accordance with Subsection 
4-41a-1101(10)(a)
, to:
(i)
access the electronic verification system to review the history within the system of 
a patient with whom the provider or agent is interacting, limited to read-only 
access for medical cannabis pharmacy agents unless the medical cannabis 
pharmacy's pharmacist in charge authorizes add and edit access;
(ii)
record a patient's recommendation from a recommending medical provider, 
including any directions of use, dosing guidelines, or caregiver indications from 
the recommending medical provider; 
(iii)
record a recommending medical provider's renewal of the provider's previous 
recommendation; and
(iv)
submit an initial application, renewal application, or application payment on 
behalf of an individual applying for any of the following:
(A)
a medical cannabis patient card;
(B)
a medical cannabis guardian card; or
(C)
a medical cannabis caregiver card;
(e)
connects with:
(i)
an inventory control system that a medical cannabis pharmacy uses to track in real 
time and archive purchases of any medical cannabis or a medical cannabis device, 
including:
(A)
the time and date of each purchase;
(B)
the quantity and type of medical cannabis or medical cannabis device 
purchased;
(C)
any cannabis production establishment, any medical cannabis pharmacy, or 
any medical cannabis courier associated with the medical cannabis or medical 
cannabis device; and
(D)
the personally identifiable information of the medical cannabis cardholder 
who made the purchase; and
(ii)
any commercially available inventory control system that a cannabis production 
establishment utilizes in accordance with Section 
4-41a-103
 to use data that the 
Department of Agriculture and Food requires by rule, in accordance with Title 
63G, Chapter 3, Utah Administrative Rulemaking Act, from the inventory 
tracking system that a licensee uses to track and confirm compliance;
(f)
provides access to:
(i)
the department to the extent necessary to carry out the department's functions and 
responsibilities under this part;
(ii)
the Department of Agriculture and Food to the extent necessary to carry out the 
functions and responsibilities of the Department of Agriculture and Food under 
Title 4, Chapter 41a, Cannabis Production Establishments and Pharmacies; and
(iii)
the Division of Professional Licensing to the extent necessary to carry out the 
functions and responsibilities related to the participation of the following in the 
recommendation and dispensing of medical cannabis:
(A)
a podiatrist licensed under Title 58, Chapter 5a, Podiatric Physician Licensing 
Act;
(B)
a pharmacist licensed under Title 58, Chapter 17b, Pharmacy Practice Act;
(C)
an advanced practice registered nurse licensed under Title 58, Chapter 31b, 
Nurse Practice Act;
(D)
a physician licensed under Title 58, Chapter 67, Utah Medical Practice Act, or 
Title 58, Chapter 68, Utah Osteopathic Medical Practice Act; or
(E)
a physician assistant licensed under Title 58, Chapter 70a, Utah Physician 
Assistant Act;
(g)
communicates dispensing information from a record that a medical cannabis 
pharmacy submits to the state electronic verification system under Subsection 
4-41a-1102(3)(a)(ii)
 to the controlled substance database;
(h)
provides access to state or local law enforcement only to verify the validity of an 
individual's medical cannabis card for the administration of criminal justice and 
through a database used by law enforcement; and
(i)
creates a record each time a person accesses the system that identifies the person who 
accesses the system and the individual whose records the person accesses.
(3)
(a)
An employee of a recommending medical provider may access the electronic 
verification system for a purpose described in Subsection 
(2)(c)
 on behalf of the 
recommending medical provider if:
(i)
the recommending medical provider has designated the employee as an individual 
authorized to access the electronic verification system on behalf of the 
recommending medical provider;
(ii)
the recommending medical provider provides written notice to the department of 
the employee's identity and the designation described in Subsection 
(3)(a)(i)
; and
(iii)
the department grants to the employee access to the electronic verification 
system.
(b)
An employee of a business that employs a recommending medical provider may 
access the electronic verification system for a purpose described in Subsection 
(2)(c)
on behalf of the recommending medical provider if:
(i)
the recommending medical provider has designated the employee as an individual 
authorized to access the electronic verification system on behalf of the 
recommending medical provider;
(ii)
the recommending medical provider and the employing business jointly provide 
written notice to the department of the employee's identity and the designation 
described in Subsection 
(3)(b)(i)
; and
(iii)
the department grants to the employee access to the electronic verification 
system.
(c)
Every two years, an employee described in Subsections 
(3)(a)
 and 
(3)(b)
 shall 
complete 
at least one hour of 
education regarding health information privacy laws 
that is offered by the department or an accredited or approved education provider that 
the department recognizes before the department may grant the employee access to 
the electronic verification system.
(4)
(a)
Subject to Subsection 
(4)(c)
, a medical cannabis pharmacy agent may access the 
electronic verification system for a purpose described in Subsection 
(2)(d)
 if:
(i)
the pharmacist-in-charge has designated the agent as an individual authorized to 
access the electronic verification system;
(ii)
the agent completes continuing education regarding health information privacy 
laws that is offered by the department or an accredited or approved education 
provider that the department recognizes;
(iii)
the agent has completed the training described in Subsection 
(4)(a)(ii)
 within the 
previous two years; and
(iv)
the department grants to the agent access to the electronic verification system.
(b)
The pharmacist-in-charge shall ensure that each medical cannabis pharmacy agent 
working in the medical cannabis pharmacy who has access to the state electronic 
verification system is in compliance with Subsection 
(4)(a)
.
(c)
 A medical cannabis pharmacy agent may not access the electronic verification 
system if the medical cannabis agent is not employed by a medical cannabis 
pharmacy.
(4)
(5)
(a)
As used in this Subsection 
(4)
(5)
, "prescribing provider" means:
(i)
a podiatrist licensed under Title 58, Chapter 5a, Podiatric Physician Licensing Act;
(ii)
an advanced practice registered nurse licensed under Title 58, Chapter 31b, Nurse 
Practice Act;
(iii)
a physician licensed under Title 58, Chapter 67, Utah Medical Practice Act, or 
Title 58, Chapter 68, Utah Osteopathic Medical Practice Act; or
(iv)
a physician assistant licensed under Title 58, Chapter 70a, Utah Physician 
Assistant Act.
(b)
A prescribing provider may access information in the electronic verification system 
regarding a patient the prescribing provider treats.
(5)
(6)
The department may release limited data that the system collects for the purpose of:
(a)
conducting medical and other department approved research;
(b)
providing the report required by Section 
26B-4-222
; and
(c)
other official department purposes.
(6)
(7)
The department shall make rules, in accordance with Title 63G, Chapter 3, Utah 
Administrative Rulemaking Act, to establish:
(a)
the limitations on access to the data in the state electronic verification system as 
described in this section; and
(b)
standards and procedures to ensure accurate identification of an individual requesting 
information or receiving information in this section.
(7)
(8)
Any person who negligently or recklessly releases any information in the state 
electronic verification system in violation of this section is guilty of a class C 
misdemeanor.
(8)
(9)
Any person who obtains or attempts to obtain information from the state electronic 
verification system by misrepresentation or fraud is guilty of a third degree felony.
(9)
(10)
(a)
Except as provided in 
Subsections (9)(c) and
Subsection
(9)(e)
 and 
Subsection 
(11)
, a person may not knowingly and intentionally use, release, publish, 
or otherwise make available to any other person information obtained from the state 
electronic verification system for any purpose other than a purpose specified in this 
section.
(b)
Each separate violation of 
this
 Subsection 
(9)
(10)
 is:
(i)
a third degree felony; and
(ii)
subject to a civil penalty not to exceed $5,000.
(c)
A law enforcement officer who uses the database used by law enforcement to access 
information in the electronic verification system for a reason that is not the 
administration of criminal justice is guilty of a class B misdemeanor.
(d)
(c)
The department shall determine a civil violation of this Subsection 
(9)
(10)
 in 
accordance with Title 
63G, Chapter 4
, Administrative Procedures Act.
(e)
(d)
Civil penalties assessed under this Subsection 
(9)
(10)
 shall be deposited into 
the General Fund.
(f)
(e)
This Subsection 
(9)
(10)
 does not prohibit a person who obtains information 
from the state electronic verification system under Subsection 
(2)(a)
, 
(c)
, or 
(f)
 from:
(i)
including the information in the person's medical chart or file for access by a 
person authorized to review the medical chart or file;
(ii)
providing the information to a person in accordance with the requirements of the 
Health Insurance Portability and Accountability Act of 1996; or
(iii)
discussing or sharing that information about the patient with the patient.
(11)
A law enforcement officer who uses the database used by law enforcement to access 
information in the electronic verification system for a reason that is not the 
administration of criminal justice is guilty of a class B misdemeanor.
Section 14. Section 
26B-4-213
 is amended to read:
26B-4-213
. Medical cannabis patient card -- Medical cannabis guardian card -- 
Conditional medical cannabis card -- Application -- Fees -- Studies.
(1)
(a)
Subject to Section 
26B-4-246
, within 15 days after the day on which an individual 
who satisfies the eligibility criteria in this section or Section 
26B-4-214
 submits an 
application in accordance with this section or Section 
26B-4-214
, the department shall
:
 issue the appropriate card to the individual for which the individual applied.
(i)
issue a medical cannabis patient card to an individual described in Subsection 
(2)(a)
;
(ii)
issue a medical cannabis guardian card to an individual described in Subsection 
(2)(b)
;
(iii)
issue a provisional patient card to a minor described in Subsection 
(2)(c)
; and
(iv)
issue a medical cannabis caregiver card to an individual described in Subsection 
26B-4-214(4).
(b)
(i)
Upon the entry of a recommending medical provider's medical cannabis 
recommendation for a patient in the state electronic verification system, either by 
the provider or the provider's employee or by a medical cannabis pharmacy 
medical provider or medical cannabis pharmacy in accordance with Subsection 
4-41a-1101(10)(a)
, the department shall issue to the patient an electronic 
conditional medical cannabis card, in accordance with this Subsection 
(1)(b)
.
(ii)
A conditional medical cannabis card is valid for the lesser of:
(A)
60 days; or
(B)
the day on which the department completes the department's review and issues 
a medical cannabis card under Subsection 
(1)(a)
, denies the patient's medical 
cannabis card application, or revokes the conditional medical cannabis card 
under Subsection 
(8)
.
(iii)
The department may issue a conditional medical cannabis card to an individual 
applying for a medical cannabis patient card for which approval of the 
Compassionate Use Board is not required.
(iv)
An individual described in Subsection 
(1)(b)(iii)
 has the rights, restrictions, and 
obligations under law applicable to a holder of the medical cannabis card for 
which the individual applies and for which the department issues the conditional 
medical cannabis card.
(2)
(a)
An individual is eligible for a medical cannabis patient card if:
(i)
(A)
the individual is at least 21 years old; or
(B)
the individual is 18, 19, or 20 years old, the individual petitions the 
Compassionate Use Board under Section 
26B-1-421
, and the Compassionate 
Use Board recommends department approval of the petition;
(ii)
the individual is a Utah resident;
(iii)
the individual's recommending medical provider recommends treatment with 
medical cannabis in accordance with Subsection 
(4)
;
(iv)
the individual signs an acknowledgment stating that the individual received the 
information described in Subsection 
(9)
; and
(v)
the individual pays to the department a fee in an amount that, subject to 
Subsection 
26B-1-310(5)
, the department sets in accordance with Section 
63J-1-504
.
(b)
(i)
An individual is eligible for a medical cannabis guardian card if the individual:
(A)
is at least 18 years old;
(B)
is a Utah resident;
(C)
(I)
is the parent or legal guardian of a minor for whom the minor's 
recommending medical provider recommends a medical cannabis treatment, 
the individual petitions the Compassionate Use Board under Section 
26B-1-421
, and the Compassionate Use Board recommends department 
approval of the petition;
 or
(II)
is the legal guardian of an incapacitated adult and provides acceptable 
proof of guardianship to the department;
(D)
the individual 
signs an acknowledgment stating that the individual received 
the information described in Subsection 
(9)
; 
and
(E)
pays to the department a fee in an amount that, subject to Subsection 
26B-1-310(5)
, the department sets in accordance with Section 
63J-1-504
, plus 
the cost of the criminal background check described in Section 
26B-4-215
.
signs an attestation under penalty of perjury that the individual is eligible for a 
medical cannabis guardian card under Section 
26B-4-246
.
(ii)
The department shall notify the Department of Public Safety of each individual 
that the department registers for a medical cannabis guardian card.
(c)
(i)
A minor is eligible for a provisional patient card if:
(A)
the minor has a qualifying condition;
(B)
the minor's recommending medical provider recommends a medical cannabis 
treatment to address the minor's qualifying condition;
(C)
one of the minor's parents or legal guardians petitions the Compassionate Use 
Board under Section 
26B-1-421
, and the Compassionate Use Board 
recommends department approval of the petition; and
(D)
the minor's parent or legal guardian is eligible for a medical cannabis guardian 
card under Subsection 
(2)(b)
 or designates a caregiver under Subsection 
(2)(d)
who is eligible for a medical cannabis caregiver card under Section 
26B-4-214
.
(ii)
The department shall automatically issue a provisional patient card to the minor 
described in Subsection 
(2)(c)(i)
 at the same time the department issues a medical 
cannabis guardian card to the minor's parent or legal guardian.
(d)
If the parent or legal guardian 
of a minor described in Subsections 
(2)(c)(i)(A)
through 
(C)
does not qualify for a medical cannabis guardian card under Subsection 
(2)(b)
, the parent or legal guardian may designate up to two caregivers in accordance 
with Subsection 
26B-4-214(1)(c)
 to ensure that the minor has adequate and safe 
access to the recommended medical cannabis treatment
.
(e)
The department shall issue a provisional patient card to an incapacitated adult if:
(i)
the incapacitated adult's legal guardian qualifies for a medical cannabis guardian 
card under Subsection 
(2)(b)
 or designates a caregiver under Subsection 
(2)(d)
who is eligible for a medical cannabis caregiver card under Section 
26B-4-214
; 
and
(ii)
the individual's recommending medical provider recommends treatment with 
medical cannabis in accordance with Subsection 
(4)
.
(3)
(a)
An individual who is eligible for a medical cannabis card described in Subsection 
(2)(a)
 or 
(b)
 shall submit an application for a medical cannabis card to the department:
(i)
through an electronic application connected to the state electronic verification 
system;
(ii)
with the recommending medical provider; and
(iii)
with information including:
(A)
the applicant's name, gender, age, and address;
(B)
the number of the applicant's government issued photo identification;
(C)
for a medical cannabis guardian card, the name, gender, and age of the 
minor
individual
 receiving a medical cannabis treatment under the cardholder's 
medical cannabis guardian card; and
(D)
for a provisional patient card, the name of the 
minor's 
parent or legal 
guardian who holds the associated medical cannabis guardian card.
(b)
(i)
If a recommending medical provider determines that, because of age, illness, or 
disability, a medical cannabis patient cardholder requires assistance in 
administering the medical cannabis treatment that the recommending medical 
provider recommends, the recommending medical provider may indicate the 
cardholder's need in the state electronic verification system, either directly or 
through the order described in Subsections 
26B-4-204(1)(b)
 and 
(c)
.
(ii)
If a recommending medical provider makes the indication described in 
Subsection 
(3)(b)(i)
:
(A)
the department shall add a label to the relevant medical cannabis patient card 
indicating the cardholder's need for assistance;
(B)
any adult who is 18 years old or older and who is physically present with the 
cardholder at the time the cardholder needs to use the recommended medical 
cannabis treatment may handle the medical cannabis treatment and any 
associated medical cannabis device as needed to assist the cardholder in 
administering the recommended medical cannabis treatment; and
(C)
an individual of any age who is physically present with the cardholder in the 
event of an emergency medical condition, as that term is defined in Section 
31A-1-301
, may handle the medical cannabis treatment and any associated 
medical cannabis device as needed to assist the cardholder in administering the 
recommended medical cannabis treatment.
(iii)
A non-cardholding individual acting under Subsection 
(3)(b)(ii)(B)
 or 
(C)
 may 
not:
(A)
ingest or inhale medical cannabis;
(B)
possess, transport, or handle medical cannabis or a medical cannabis device 
outside of the immediate area where the cardholder is present or with an intent 
other than to provide assistance to the cardholder; or
(C)
possess, transport, or handle medical cannabis or a medical cannabis device 
when the cardholder is not in the process of being dosed with medical cannabis.
(4)
(a)
Except as provided in Subsection 
(4)(b)
, a recommending medical provider may 
not recommend medical cannabis to a patient through a virtual visit.
(b)
A recommending medical provider may recommend medical cannabis to a patient 
through a virtual visit if the patient:
(i)
is on hospice or has a terminal illness according to the patient's medical provider;
(ii)
is a resident of an assisted living facility, as defined in Section 
26B-2-201
, or a 
nursing care facility, as defined in Section 
26B-2-201
;
(iii)
has previously received a medical cannabis recommendation from the 
recommending medical provider through a face-to-face visit; or
(iv)
is a current patient of the recommending medical provider and has met with the 
recommending medical provider face-to-face previously.
(c)
A recommending medical provider shall:
(i)
before recommending or renewing a recommendation for medical cannabis
 in a 
medicinal dosage form or a cannabis product in a medicinal dosage form
:
(A)
verify the patient's and, for a minor patient, the minor patient's parent or legal 
guardian's government issued photo identification described in Subsection 
(3)(a)
;
(B)
review any record related to the patient and, for a minor patient, the patient's 
parent or legal guardian accessible to the recommending medical provider 
including in the controlled substance database created in Section 
58-37f-201
; 
and
(C)
consider the recommendation in light of the patient's qualifying condition, 
history of substance use or opioid use disorder, and history of medical cannabis 
and controlled substance use during a visit with the patient; and
(ii)
state in the recommending medical provider's recommendation that the patient:
(A)
suffers from a qualifying condition, including the type of qualifying condition; 
and
(B)
may benefit from treatment with 
cannabis in a medicinal dosage form or a 
cannabis product in a medicinal dosage form
medical cannabis
.
(5)
(a)
Except as provided in Subsection 
(5)(b)
 or 
(c)
, a medical cannabis card that the 
department issues under this section is valid for the lesser of:
(i)
an amount of time that the recommending medical provider determines; or
(ii)
one year from the day the card is issued.
(b)
(i)
A medical cannabis card that the department issues in relation to a terminal 
illness described in Section 
26B-4-203
 expires after one year.
(ii)
The recommending medical provider may revoke a recommendation that the 
provider made in relation to a terminal illness described in Section 
26B-4-203
 if 
the medical cannabis cardholder no longer has the terminal illness.
(c)
A medical cannabis card that the department issues in relation to acute pain as 
described in Section 
26B-4-203
 expires 30 days after the day on which the 
department first issues a conditional or full medical cannabis card.
(6)
(a)
A medical cannabis patient card or a medical cannabis guardian card is renewable 
if:
(i)
at the time of renewal, the cardholder meets the requirements of Subsection 
(2)(a)
or 
(b)
; or
(ii)
the cardholder received the medical cannabis card through the recommendation of 
the Compassionate Use Board under Section 
26B-1-421
.
(b)
The recommending medical provider who made the underlying recommendation for 
the card of a cardholder described in Subsection 
(6)(a)
 may renew the cardholder's 
card through phone or video conference with the cardholder, at the recommending 
medical provider's discretion.
(c)
Before having access to a renewed card, a cardholder under Subsection 
(2)(a)
 or 
(b)
shall pay to the department a renewal fee in an amount that:
(i)
subject to Subsection 
26B-1-310(5)
, the department sets in accordance with 
Section 
63J-1-504
; and
(ii)
may not exceed the cost of the relatively lower administrative burden of renewal 
in comparison to the original application process.
(d)
If a minor meets the requirements of Subsection 
(2)(c)
, the minor's provisional 
patient card renews automatically at the time the minor's parent or legal guardian 
renews the parent or legal guardian's associated medical cannabis guardian card.
(7)
(a)
A cardholder under this section shall carry the cardholder's valid medical cannabis 
card with the patient's name.
(b)
(i)
A medical cannabis patient cardholder or a provisional patient cardholder may 
purchase, in accordance with this part and the recommendation underlying the 
card, 
cannabis in a medicinal dosage form, a cannabis product in a medicinal 
dosage form,
medical cannabis
 or a medical cannabis device.
(ii)
A cardholder under this section may possess or transport, in accordance with this 
part and the recommendation underlying the card, 
cannabis in a medicinal dosage 
form, a cannabis product in a medicinal dosage form,
medical cannabis
 or a 
medical cannabis device.
(iii)
To address the qualifying condition underlying the medical cannabis treatment 
recommendation:
(A)
a medical cannabis patient cardholder or a provisional patient cardholder may 
use medical cannabis or a medical cannabis device; and
(B)
a medical cannabis guardian cardholder may assist the associated provisional 
patient cardholder with the use of medical cannabis or a medical cannabis 
device.
(8)
(a)
The department may revoke a medical cannabis card that the department issues 
under this section if:
(i)
the recommending medical provider withdraws the medical provider's 
recommendation for medical cannabis; or
(ii)
the cardholder:
(A)
violates this part; or
(B)
is convicted under state or federal law of, after March 17, 2021, a drug 
distribution offense.
(b)
The department may not refuse to issue a medical cannabis card to a patient solely 
based on a prior revocation under Subsection 
(8)(a)(i)
.
(9)
The department shall establish by rule, in accordance with Title 63G, Chapter 3, Utah 
Administrative Rulemaking Act, a process to provide information regarding the 
following to an individual receiving a medical cannabis card:
(a)
risks associated with medical cannabis treatment;
(b)
the fact that a condition's listing as a qualifying condition does not suggest that 
medical cannabis treatment is an effective treatment or cure for that condition, as 
described in Subsection 
26B-4-203(1)
; and
(c)
other relevant warnings and safety information that the department determines.
(10)
The department may establish procedures by rule, in accordance with Title 63G, 
Chapter 3, Utah Administrative Rulemaking Act, to implement the application and 
issuance provisions of this section.
(11)
(a)
The department shall establish by rule, in accordance with Title 63G, Chapter 3, 
Utah Administrative Rulemaking Act, a process to allow an individual from another 
state to register with the department in order to purchase medical cannabis or a 
medical cannabis device from a medical cannabis pharmacy while the individual is 
visiting the state.
(b)
The department may only provide the registration process described in Subsection 
(11)(a)
:
(i)
to a nonresident patient; and
(ii)
for no more than two visitation periods per calendar year of up to 21 calendar 
days per visitation period.
(12)
(a)
A person may submit to the department a request to conduct a research study 
using medical cannabis cardholder data that the state electronic verification system 
contains.
(b)
The department shall review a request described in Subsection 
(12)(a)
 to determine 
whether an institutional review board, as that term is defined in Section 
26B-4-201
, 
could approve the research study.
(c)
At the time an individual applies for a medical cannabis card, the department shall 
notify the individual:
(i)
of how the individual's information will be used as a cardholder;
(ii)
that by applying for a medical cannabis card, unless the individual withdraws 
consent under Subsection 
(12)(d)
, the individual consents to the use of the 
individual's information for external research; and
(iii)
that the individual may withdraw consent for the use of the individual's 
information for external research at any time, including at the time of application.
(d)
An applicant may, through the medical cannabis card application, and a medical 
cannabis cardholder may, through the state central patient portal, withdraw the 
applicant's or cardholder's consent to participate in external research at any time.
(e)
The department may release, for the purposes of a study described in this Subsection 
(12)
, information about a cardholder under this section who consents to participate 
under Subsection 
(12)(c)
.
(f)
If an individual withdraws consent under Subsection 
(12)(d)
, the withdrawal of 
consent:
(i)
applies to external research that is initiated after the withdrawal of consent; and
(ii)
does not apply to research that was initiated before the withdrawal of consent.
(g)
The department may establish standards for a medical research study's validity, by 
rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking 
Act.
(13)
The department shall record the issuance or revocation of a medical cannabis card 
under this section in the controlled substance database.
Section 15. Section 
26B-4-214
 is amended to read:
26B-4-214
. Medical cannabis caregiver card -- Registration -- Renewal -- 
Revocation.
(1)
(a)
A 
cardholder described in Section 
26B-4-213
medical cannabis patient 
cardholder or medical cannabis guardian cardholder
 may designate up to two 
individuals, or an individual and a facility in accordance with Subsection 
(1)(b)
, to 
serve as a designated caregiver for the cardholder.
(b)
(i)
A 
cardholder described in Section 
26B-4-213
medical cannabis patient 
cardholder or medical cannabis guardian cardholder
 may designate one of the 
following types of facilities as one of the caregivers described in Subsection 
(1)(a)
:
(A)
for a patient or resident, an assisted living facility, as that term is defined in 
Section 
26B-2-201
;
(B)
for a patient or resident, a nursing care facility, as that term is defined in 
Section 
26B-2-201
; or
(C)
for a patient, a general acute hospital, as that term is defined in Section 
26B-2-201
.
(ii)
A facility may:
(A)
assign one or more employees to assist patients with medical cannabis 
treatment under the caregiver designation described in this Subsection 
(1)(b)
; 
and
(B)
receive a medical cannabis shipment from a medical cannabis pharmacy or a 
medical cannabis courier on behalf of the medical cannabis cardholder within 
the facility who designated the facility as a caregiver.
(iii)
The department shall make rules to regulate the practice of facilities and facility 
employees serving as designated caregivers under this Subsection 
(1)(b)
.
(c)
A parent or legal guardian described in Subsection 
26B-4-213(2)(d)
, in consultation 
with the minor and the minor's recommending medical provider, may designate up to 
two individuals to serve as 
a
 designated 
caregiver
caregivers
 for the minor, if the 
department determines that the parent or legal guardian is not eligible for a medical 
cannabis guardian card under Section 
26B-4-213
.
(d)
(i)
Upon the entry of a caregiver designation under Subsection 
(1)(c)
 by a patient 
with a terminal illness described in Section 
26B-4-203
, the department shall issue 
to the designated caregiver an electronic conditional medical cannabis caregiver 
card, in accordance with this Subsection 
(1)(d)
.
(ii)
A conditional medical cannabis caregiver card is valid for the lesser of:
(A)
60 days; or
(B)
the day on which the department completes the department's review and issues 
a medical cannabis caregiver card under Subsection 
(1)(a)
, denies the patient's 
medical cannabis caregiver card application, or revokes the conditional 
medical cannabis caregiver card under Section 
26B-4-246
.
(iii)
The department may issue a conditional medical cannabis card to an individual 
applying for a medical cannabis patient card for which approval of the 
Compassionate Use Board is not required.
(iv)
An individual described in Subsection 
(1)(b)(iii)
 has the rights, restrictions, and 
obligations under law applicable to a holder of the medical cannabis card for 
which the individual applies and for which the department issues the conditional 
medical cannabis card.
(2)
An individual that the department registers as a designated caregiver under this section 
and a facility described in Subsection 
(1)(b)
:
(a)
for an individual designated caregiver, may carry a valid medical cannabis caregiver 
card;
(b)
in accordance with this part, may purchase, possess, transport, or assist the patient in 
the use of medical cannabis or a medical cannabis device on behalf of the designating 
medical cannabis cardholder;
(c)
may not charge a fee to an individual to act as the individual's designated caregiver 
or for a service that the designated caregiver provides in relation to the role as a 
designated caregiver; and
(d)
may accept reimbursement from the designating medical cannabis cardholder for 
direct costs the designated caregiver incurs for assisting with the designating 
cardholder's medicinal use of cannabis.
(3)
(a)
The department shall:
(i)
within 15 days after the day on which an individual submits an application in 
compliance with this section, issue a medical cannabis card to the applicant if the 
applicant:
(A)
is designated as a caregiver under Subsection 
(1)
;
(B)
is eligible for a medical cannabis caregiver card under Subsection 
(4)
; and
(C)
complies with this section; and
(ii)
notify the Department of Public Safety of each individual that the department 
registers as a designated caregiver.
(b)
The department shall ensure that a medical cannabis caregiver card contains the 
information described in Subsections 
(5)(b)
 and 
(3)(c)(i)
.
(c)
(b)
If a 
cardholder described in Section 
26B-4-213
medical cannabis patient 
cardholder or medical cannabis guardian cardholder
 designates an individual as a 
caregiver who already holds a medical cannabis caregiver card, the individual with 
the medical cannabis caregiver card:
(i)
shall report to the department the information required of applicants under 
Subsection 
(5)(b)
 regarding the new designation;
(ii)
if the individual makes the report described in Subsection 
(3)(c)(i)
(3)(b)(i)
, is 
not required to file an application for another medical cannabis caregiver card;
 and
(iii)
may receive an additional medical cannabis caregiver card in relation to each 
additional medical cannabis patient who designates the caregiver
; and
.
(iv)
is not subject to an additional background check.
(4)
An individual is eligible for a medical cannabis caregiver card if the individual:
(a)
is at least 21 years old;
(b)
is a Utah resident;
 and
(c)
pays to the department a fee in an amount that, subject to Subsection 
26B-1-310(5)
, 
the department sets in accordance with Section 
63J-1-504
, plus the cost of the 
criminal background check described in Section 
26B-4-215
; and
signs an attestation 
under penalty of perjury that the individual is eligible for a medical cannabis 
caregiver card under Section 
26B-4-246
.
(d)
signs an acknowledgment stating that the applicant received the information 
described in Subsection 
26B-4-213(9)
.
(5)
An eligible applicant for a medical cannabis caregiver card shall:
(a)
submit an application for a medical cannabis caregiver card to the department 
through an electronic application connected to the state electronic verification 
system; and
(b)
submit the following information in the application described in Subsection 
(5)(a)
:
(i)
the applicant's name, gender, age, and address;
(ii)
the name, gender, age, and address of the 
cardholder described in Section 
26B-4-213
medical cannabis patient cardholder or medical cannabis guardian 
cardholder
 who designated the applicant;
(iii)
if a medical cannabis guardian cardholder designated the caregiver, the name, 
gender, and age of the minor receiving a medical cannabis treatment in relation to 
the medical cannabis guardian cardholder; and
(iv)
any additional information that the department requests to assist in matching the 
application with the designating medical cannabis patient.
(6)
Except as provided in Subsection 
(6)(b)
, a 
A 
medical cannabis caregiver card that the 
department issues under this section is valid for the lesser of:
(a)
an amount of time that the 
cardholder described in Section 
26B-4-213
medical 
cannabis patient cardholder or medical cannabis guardian cardholder
 who designated 
the caregiver determines; or
(b)
the amount of time remaining before the card of the 
cardholder described in Section 
26B-4-213
medical cannabis patient cardholder or medical cannabis guardian 
cardholder
 expires.
(7)
(a)
If a designated caregiver meets the requirements of Subsection 
(4)
, the designated 
caregiver's medical cannabis caregiver card renews automatically at the time the 
cardholder described in Section 
26B-4-213
medical cannabis patient cardholder or 
medical cannabis guardian cardholder
 who designated the caregiver:
(i)
renews the cardholder's card; and
(ii)
renews the caregiver's designation, in accordance with Subsection 
(7)(b)
.
(b)
The department shall provide a method in the card renewal process to allow a 
cardholder described in Section 
26B-4-213
medical cannabis patient cardholder or 
medical cannabis guardian cardholder
 who has designated a caregiver to:
(i)
signify that the cardholder renews the caregiver's designation;
(ii)
remove a caregiver's designation; or
(iii)
designate a new caregiver.
(8)
The department shall record the issuance or revocation of a medical cannabis card under 
this section in the controlled substance database.
Section 16. Section 
26B-4-248
 is enacted to read:
26B-4-248
. Funds for patient vouchers.
(1)
The department shall contract with a nonprofit entity that provides assistance to medical 
cannabis cardholders for purchasing medical cannabis or a medical cannabis device.
(2)
Subject to available funds, the contracted nonprofit entity may provide monthly $150 
vouchers to a medical cannabis pharmacy for purchasing products in accordance with 
this section.
(3)
A medical cannabis patient is eligible for a voucher if the individual is:
(a)
an active medical cannabis cardholder patient; and
(b)
enrolled in Medicaid or Medicare.
(4)
The department may make rules to effectuate the program described in this section in 
accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act.
(5)
A contracted nonprofit entity shall provide the department an accounting each quarter of:
(a)
how money was used; and
(b)
other metrics determined relevant by the department.
(6)
The contracted non
profit entity shall use all money received from the department under 
this section for vouchers described in this section.
Section 17. Section 
63I-2-236
 is amended to read:
63I-2-236
. Repeal dates: Title 36.
(1)
Section 
36-12-8.2
, Medical cannabis governance structure working group, is repealed 
July 1, 
2026
2027
.
(2)
Section 
36-29-109
, Utah Broadband Center Advisory Commission, is repealed 
November 30, 2027.
Section 18. 
Repealer.
Designated caregiver -- Guardian -- Criminal background check.
Section 19. 
Effective Date.
This bill takes effect on 
May 6, 2026
.
3-5-26 9:04 AM